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ABSTRACT OF THE DISSERTATION
Understanding the Interactions of Developing Thymocytes and Antigen Presenting Cells
in the Thymic Medulla
By
Justin Shaun Arnold Perry
Doctor of Philosophy in Biology and Biomedical Sciences
Immunology
Washington University in St. Louis, 2016
Professor Chyi-Song Hsieh, Chair
Various thymic APC subsets have been invoked in deletional tolerance and Treg cell
induction, but previous studies either assessed total T cell numbers or used TCR
transgenic lines, obscuring roles that individual thymic APC subsets might serve for
particular antigen-specific T cell populations. Utilizing T cell receptor sequencing, we
found that medullary thymic epithelial cells (mTECs) and bone marrow-derived (BM)
APCs delete or select unique conventional and Treg cell TCR repertoires,
demonstrating distinct roles for these APCs. We show that BM APCs and mTECs each
contribute to Aire-dependent T cell tolerance development, albeit through either
cooperative or autologous antigen presentation respectively, and that cooperative
antigen transfer is likely performed by thymic CD8+ DCs. Using our established TCR
sequencing approach, In addition, we sought to understand CD8+ DC-mediated
cooperative antigen presentation further. We quantified the extent of CD8+ DCdependent Treg cell and negative selection and the proportion of this selection that is
achieved through Aire-dependent cooperative antigen transfer. We also found that
CD36 expression by CD8+ DCs facilitates Aire-dependent cooperative antigen transfer
ix

both in vivo and via TCR sequencing. Finally, we found that in the absence of thymic
CD8+ DCs or CD36 expression; direct allo-tolerance fails to develop leading to
catastrophic acute GVHD.
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CHAPTER 1
Background and Significance
A defining feature of adaptive immunity is its ability to harness somatic gene
rearrangement to generate a diverse antigen receptor repertoire, which allows for the
recognition of a variety of pathogens including those not previously encountered by the
host species. For most T cells, rearrangement of the TCR  and  chains occurs early
during T cell development in a specialized organ–the thymus. Thymocytes expressing
functional TCR genes can then undergo positive selection, where weak TCR recognition
of self-antigen MHC complexes on cortical thymic epithelial cells allows continued T cell
development and CD4 and CD8 lineage commitment (Klein et al., 2014; Stritesky et al.,
2012; Vrisekoop et al., 2014). These mechanisms serve to generate the T cell
population responsible for immunity to pathogens.
However, the potential cost of this randomly generated TCR repertoire is the
presence of TCRs that recognize self-antigens and contribute to the pathogenesis of
autoimmune disease. An important component of T cell development is therefore to limit
the autoreactivity within the T cell population in the thymus prior to their release into the
periphery of the host. This process in the thymus, generally referred to as central
tolerance, is achieved through deletion of autoreactive clones (i.e. negative selection),
and for CD4+ T cells, diversion of autoreactive clones into the regulatory T (Treg) cell
lineage (Hsieh et al., 2012b; Klein and Jovanovic, 2011; Rudensky, 2011), a subset of T
cells that inhibit, rather than induce, inflammatory responses (Sakaguchi and Powrie,
2007).
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Although central tolerance can occur throughout the thymus (Stritesky et al., 2012),
the majority of this process appears to occur in the medulla, which consists of a
secondary lymphoid tissue-like structure populated by hematopoiesis-derived dendritic
cells, macrophages, and B cells; as well as thymic epithelial cells (mTECs) and
fibroblasts (Klein, 2009; Koble and Kyewski, 2009a). Thus, a diverse assortment of cell
types appears to be involved in central tolerance.

Role of mTECs and BM APCs in self-tolerance
The importance of TCR specificity in the process of T cell tolerance necessitates an
effective means of thymic presentation of the self-antigenic repertoire, including those
antigens expressed in an organ specific manner. In both thymic compartments, it
appears that hematopoietic and non-hematopoietic cells contribute to T cell tolerance
(Atibalentja et al., 2011; Gallegos and Bevan, 2004; Hinterberger et al., 2010; Hubert et
al., 2011; Koble and Kyewski, 2009b; Proietto et al., 2008b; Taniguchi et al., 2012).
Although T cell tolerance occurs at any stage in their development after rearrangement
of a functional TCR (McCaughtry et al., 2008; Stritesky et al., 2013), the majority of T
cell tolerance appears to occur in the thymic medulla (reviewed in (Anderson and Su,
2011; Mathis and Benoist, 2009b)). We discuss here our current understanding of how
the array of medullary APC subsets contributes to thymic T cell tolerance.

mTEC antigen presentation
it remains technically challenging to delineate the specific contributions of each
medullary APC to T cell tolerance development (Klein et al., 2014). For instance,
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reduction or deletion of MHCII on either compartment results in only a partial effect on
Treg cell numbers or on negative selection (Aschenbrenner et al., 2007; Hinterberger et
al., 2010). Additionally, mTECs require crosstalk with thymocytes via MHCII for
successful organization of the medulla (Irla et al., 2008), precluding targeted deletion of
MHCII on mTECs. An important advance came from Klein and colleagues who
developed a mouse with mTEC-targeted reduction of MHCII expression using Aire
promoter driven shRNA knockdown of the class II transactivator (C2TAkd) (Hinterberger
et al., 2010), which does so without altering medulla organization. They observed a
modest increase in the polyclonal CD4SP compartment due to loss of negative
selection as well as increased Treg cell selection to a model antigen expressed in
mTECs. Thus, these data demonstrate that direct mTEC antigen presentation plays a
role in T cell tolerance.
mTECs, however, are known to be inefficient at using conventional antigen
presenting pathways (Atibalentja et al., 2009; Klein et al., 2001). Moreover, conventional
pathways are not focused on presenting proteins generated endogenously within the
cell. Current data suggests that mTECs use macroautophagy for presentation of cellautonomous antigens (Aichinger et al., 2013a; Nedjic et al., 2008b). Transplantation of
Atg5–/– autophagy-deficient thymi under the kidney capsule of select TCR transgenic
mice resulted in increased CD4SP numbers, suggesting decrease negative selection. In
addition, T cells selected on Atg5–/– thymi were capable of inducing multi-organ
autoimmunity (Nedjic et al., 2008b). Recent work suggested that mTECs specifically
require autophagy to load peptides onto MHCII from model antigens targeted to the
autophagosome or the mitochondria, but not the cell membrane (Aichinger et al.,
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2013a). These data on mTECs are consistent with reports from other contexts showing
a role for autophagy in loading of intracellular antigen onto MHC class II (Dengjel et al.,
2005; English et al., 2009; Lee et al., 2010; Paludan et al., 2005; Schmid et al., 2007).
However, another group reported that mTEC-targeted deletion of Atg7 via the K14Cre resulted in no alteration of the thymocyte compartment or autoimmune disease
despite ablation of autophagy in TECs (Sukseree et al., 2012). One possible
explanation for the discrepancy between results from Atg5 versus Atg7 deficient mice is
that autophagy associated antigen presentation may utilize different components than
the autophagy pathway itself (Lee et al., 2010; Li et al., 2015; Liu et al., 2015; Zhao et
al., 2008). Interestingly, a recent report suggested that knockdown of Clec16a, an
autophagy/mitophagy-associated protein (Soleimanpour et al., 2015; Soleimanpour et
al., 2014), is protective in the NOD model of type 1 diabetes (Schuster et al., 2015).
They proposed that this was due to alterations in the generation and presentation of
ligands by mTECs responsible for selecting diabetogenic T cells, rather than tolerance
to islet associated antigens. Additional studies are required to determine whether an
effect on mTEC antigen presentation explains the observation that an CLEC16A SNP
results in increased susceptibility to human type 1 diabetes (Polychronakos and Li,
2011).
In summary, these data suggest that direct mTEC presentation of intracellular
antigens to T cells is mediated at least in part by autophagy proteins. Future work is
required to dissect the specific mechanism by which intracellular antigens are
processed via the canonical autophagy versus alternative antigen presentation
pathways in mTECs. Moreover, future analysis of TCR repertoires in mice with
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autophagy deficient mTECs would be useful to determine the extent that autophagy
affects mTEC antigen presentation.

BM APCs
Whereas mTECs arise within the thymus, the other major medullary APC subsets
arise from the bone marrow. Several lines of evidence suggest an important role for BM
APCs in T cell tolerance. First, deletion of MHCII on BM APCs results in an increase in
the CD4SP thymocyte compartment (Aschenbrenner et al., 2007; Hinterberger et al.,
2010; Ohnmacht et al., 2009), suggestive of a role in negative selection. The impact of
MHCII deletion on BM APCs on Treg cell numbers have been reported to be mild
(Aschenbrenner et al., 2007; Hinterberger et al., 2010; Liston et al., 2008; Ohnmacht et
al., 2009; van Meerwijk et al., 1997) to moderate (Román et al., 2010). Second, use of
neo-self antigen systems such as RIP-membrane OVA (mOVA) suggest that BM APCs,
and in particular DCs, can contribute to both negative and Treg cell selection of antigenspecific TCRs (Atibalentja et al., 2011; Baba et al., 2009a; Hubert et al., 2011; Oh et al.,
2013).

Cooperation between BM APCs and mTECs
Antigen transfer from mTECs to BM APCs constitutes another pathway through
which T cell tolerance occurs (Gallegos and Bevan, 2004; Hinterberger et al., 2010;
Hubert, 2011; Koble and Kyewski, 2009a; Perry et al., 2014; Taniguchi et al., 2012). It is
apparent that certain neo-self antigen transgenic models, such as nuclear or membrane
OVA, require transfer from mTECs to thymic DCs for deletion of OVA-specific CD4+ and
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CD8+ thymocytes (Aschenbrenner et al., 2007; Gallegos and Bevan, 2004). Antigen
transfer was also reported by a separate group, although they also observed a
concurrent role for cell-autonomous antigen presentation (Hubert et al., 2011). In
addition to model antigens, Anderson and colleagues examined this issue using MHCII
tetramers with interphotoreceptor retinoid-binding protein (IRBP), a naturally occurring
Aire-dependent peripheral tissue antigen (PTA) (Taniguchi et al., 2012). Consistent with
the notion that IRBP undergoes cooperative antigen presentation, they observed that
deletion of MHCII on BM APCs resulted in a significant increase in tetramer-positive
cells, despite IRBP expression being restricted to mTECs. .

Role of Aire in T cell tolerance
A key component of tolerance is the presentation of self-antigens in the thymus. It
has become clear that the Autoimmune Regulator (Aire) protein plays a critical role in
this process by inducing the expression of tissue specific antigens in mTECs as well as
mTEC function and development (reviewed in (Abramson et al., 2010; Akirav et al.,
2011; Anderson and Su, 2011; Mathis and Benoist, 2009a)).

Control of tissue specific antigen production by Aire
It is clear that generation of PTA is one of the main functions of Aire (Taniguchi and
Anderson, 2011). As an mTEC matures into the CD80+ MHCII+ phenotype, Aire
expression becomes detectable which coincides with a dramatic increase in PTA
expression. Despite the ability of the mTEC population to produce thousands of unique
PTAs, previous reports estimate that a single mTEC expresses only ~1-3% of the total
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PTA ligandome (Abramson et al., 2010). How a small subset of cells expressing a
fraction of the possible PTA ligandome at any given time could facilitate tolerance
remains unclear. Two recent studies utilizing single cell RNA-sequencing (scRNA-seq)
address this complex process (Brennecke et al., 2015; Meredith et al., 2015). Analysis
of ~200 individual mature mTECs confirmed previous estimates showing that each
mTEC expressed only a small fraction of the total PTA ligandome. Combined, however,
mTECs expressed the majority of known PTAs. Interestingly, both studies found that
correlated sets of PTAs were generated in multiple distinct, small fractions of mTECs,
providing evidence for a mosaic model of PTA expression (Brennecke et al., 2015;
Meredith et al., 2015). Additionally, these “co-expressed genes” tended to cluster in the
genome (Meredith et al., 2015), providing a potential explanation for why a set of
mTECs express a small, related fraction of PTAs at a particular time. Taken together, it
appears that subsets of mature mTECs express clusters of PTAs and together these
clusters of mTECs converge to express the breadth of the PTA ligandome.
Recently, Takayanag and colleagues have identified the transcriptional regulator
Fezf2 as an Aire-independent mechanism for inducing PTA production in mTECs
(Takaba et al.). Unlike Aire, deletion of Fezf2 is lethal in young (~3-4 week old) mice
due to a failure of forebrain neuronal development and subsequent malnutrition (Eckler
and Chen, 2014). Moreover, Fezf2 is regulated by the lymphotoxin receptor , whereas
Aire is affected by the RANK/CD40 pathway. TEC-specific deletion of Fezf2 via Foxn1cre results in lymphocytic infiltrates in the lung, liver, kidneys and small intestine but not
the retina or pancreas of C57BL/6 mice, consistent with Fezf2 being required for
expression of a different array of PTAs than Aire (Takaba et al., 2015). The discovery of
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Fezf2 poses interesting new questions in its relationship to Aire and its relevance in
human disease. Nonetheless, it appears that PTA expression in mTECs can be
generated via multiple mechanisms.
The small numbers of mTECs that express any given PTA raises the question of
how thymocytes are efficiently exposed to those antigens. One hypothesis is that the
motility of thymocytes could allow them to scan hundreds to thousands of APCs over
the period of time it resides in the medulla (Klein et al., 2014). Given the findings above,
encountering ~200-500 mTECs would be sufficient for a single thymocyte to see the
majority of the PTA ligandome. Another non-mutually exclusive possibility, as discussed
in the preceding section, is that antigen transfer to BM APCs can increase the overall
presentation of a given antigen.
Early studies supported the notion that Aire-induced PTA facilitates negative
selection (Anderson et al., 2005; Liston et al., 2003; Taniguchi et al., 2012). However,
its role in Treg cell selection has been controversial. Initial reports suggested that Aire is
not required for Treg cell selection as Aire deletion does not alter polyclonal Treg cell
numbers (Anderson et al., 2005). Additionally, Ignatowicz and colleagues reported that
the absence of Aire has no effect on the Treg cell TCR repertoire (Daniely et al., 2010).
On the other hand, Treg cell selection of TCR transgenic cells can be induced by the
genetic expression of cognate antigen on Aire+ mTECs (Aschenbrenner et al., 2007).
Furthermore, a recent report by Savage and colleagues showed that two independent
prostate specific TCR transgenic cells underwent Aire-dependent Treg cell selection
(Malchow et al., 2013). Together, these data suggest that Aire play a role in negative
selection and can affect Treg cell selection at least in a limited capacity.
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As discussed above, the rationale for antigen transfer from mTECs might be to
expand the number of APCs presenting any given antigen considering the stochastic
nature of Aire-dependent PTA expression. This would increase the likelihood that a
single thymocyte can encounter all PTAs expressed in the thymus, and functionally
increase the “antigenic niche size” for Treg and negative selection. Another intriguing
possibility is that transfer to BM APCs insures that the processing and presentation of
antigens are consistent between the thymus and periphery. For example, cathepsins
are differentially expressed between TECs and BM APCs (Bania et al., 2003; Beers et
al., 2005; Nakagawa et al., 1998; Stoeckle et al., 2012), potentially resulting in the
loading of different peptide fragments onto the MHC II of these APC subsets. Although
this hypothesis has not been tested, a dichotomy between thymic and peripheral
antigen presentation has been hypothesized as a determining factor for the loss of
tolerance to insulin in NOD mice (Calderon et al., 2014). Thus, cooperative antigen
presentation may limit discordant antigen peptide presentation by thymic versus
peripheral APCs.

BM-derived APC subsets
There are a variety of different BM-derived APC subsets in the thymic medulla,
including B cells, macrophages, and DCs, consisting of conventional DCs and pDCs
(Wu and Shortman, 2005), each with potentially unique roles in thymic T cell tolerance.

Conventional DCs
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The conventional DC subset is comprised of the CD8+ and SIRP+ DC subsets (Li
et al., 2009). It remains to be seen whether these thymic DC subsets can be further
subdivided, such as that seen in the peripheral tissue SIRP+ DC equivalent, the
CD11b+ DCs (Satpathy et al., 2012). While these two cDC subsets are both efficient at
presenting exogenous antigen, there are notable difference. For instance, thymic
SIRP+ DCs originate from outside of the thymus, presumably entering the thymus via
the vascular plexus connected to the outer portion of the medulla (Li et al., 2009; Wu
and Shortman, 2005). By contrast, CD8+ DCs arise primarily within the thymus.
SIRP+ DCs also show a different localization, and generally remain close to vascular
regions within the medulla whereas CD8+ DCs are distributed throughout the thymus
parenchyma (Klein et al., 2014).
These differences suggest non-overlapping functions in antigen presentation (Oh
and Shin, 2015). For instance, SIRP+ DCs have been shown to efficiently present
blood-borne antigen for negative and Treg cell selection, potentially related to their
predilection for vascular regions (Atibalentja et al., 2009; Atibalentja et al., 2011; Baba
et al., 2009a; Proietto et al., 2008b).
The extra-thymic origin of SIRP+ DCs may also be a vehicle for antigen transport
into the thymus. One study using fluorescent beads too large to permeate into the
thymus showed that SIRP+ DCs and pDCs, but not CD8+ DCs, have the capacity to
acquire and transport antigen into the thymus (Wendland et al., 2007). Similar findings
were reported using skin-painting of FITC (Bonasio et al., 2006). Finally, mOVA
expressed specifically in cardiomyocytes led to deletion of OT-II thymocytes mediated
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by circulating DCs (Bonasio et al., 2006). Taken together, SIRP+ DCs may present
extra-thymic antigen both via DC migration as well as capture of blood-borne antigens.
Factors that determine if a SIRP+ DC enters the thymus with extra-thymic antigen
remain unclear. In addition, the relative importance of this extra-thymic versus intrathymic antigen presentation is unknown. Another question is whether the extra-thymic
antigen presentation pathway can induce tolerance to pathogens or commensal
bacteria. New tools are therefore required to understand the importance of SIRP+ DCs
and the extent that they present extra- versus intra-thymic antigens.
Unlike SIRP+ DCs, CD8+ DCs are more likely to present antigen generated within
the thymus because of their localization (Joffre et al., 2012). CD8+ DCs constitutively
express the chemokine receptor XCR1 (Bachem et al., 2012) which directs migration in
response to XCL1 from mTECs (Lei et al., 2011). This crosstalk between CD8+ DCs
and mTECs is supported by the observation that XCL1-deficient mice show a decrease
in Treg cell numbers and transfer of thymocytes from XCL1 deficient mice into nude
mice develop dacryoadenitis (Lei et al., 2011). Moreover, the enhanced ability of CD8+
DCs to cross-present exogenous antigen on MHCI allows concomitant CD8 + T cell
tolerance, as observed in both in vitro (Proietto et al., 2008a) and in vivo studies
(Gallegos and Bevan, 2004).
My thesis will cover three main areas: 1) the contributions of aire and antigen
presenting cell subsets to the generation of self-tolerance in the thymus, 2) evaluate the
necessity of antigen transfer from Aire-dependent mTECs to CD8+ DCs for T cell
tolerance, and 3) determine the molecular mechanism for Aire-dependent mTEC to
CD8+ DC antigen transfer. Taken together, my work has broadened our understanding
11

of T cell development and the unique roles each antigen presenting cell plays in this
process.
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CHAPTER 2
Contributions of Aire and antigen presenting cell subsets to the generation of selftolerance in the thymus

The results presented in this chapter have been adapted from a manuscript published in
Immunity, 2014.

Abstract
The contribution of thymic APC subsets in selecting a self-tolerant T cell population
remains unclear. We show that BM APCs and mTECs played non-overlapping roles in
shaping the TCR repertoire by deletion and Treg cell selection of distinct TCRs. Aire,
which induces tissue-specific-antigen expression in mTECs, affected the TCR repertoire
in a manner distinct from mTEC presentation. Approximately half of Aire-dependent
deletion or Treg cell selection utilized a pathway dependent on antigen presentation by
BM APCs. Batf3-dependent CD8α+ DCs were the crucial BM APC for Treg cell selection
via this pathway, showing enhanced ability to present antigens from stromal cells.
These results demonstrate the division of function between thymic APCs in shaping the
self-tolerant TCR repertoire, and reveal an unappreciated cooperation between mTECs
and CD8α+ DCs for presentation of Aire-induced self-antigens to developing
thymocytes.
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Introduction
The enormous diversity of adaptive immune receptors allows for the recognition
of a wide variety of pathogens, but comes at the potential cost of self-recognition and
autoimmunity. For CD4+ T cells, self-tolerance starts during T cell maturation in the
thymus where they are instructed by APCs found primarily in the thymic medulla
(Derbinski and Kyewski, 2010; Klein et al., 2014; Stritesky et al., 2012; Weissler, 2014).
CD4+ T cells bearing TCRs that recognize self-antigens at this stage can be eliminated
by negative selection, which prevents the release of autoreactive Tconv cells into the
periphery (Palmer, 2003; Stritesky et al., 2012). Alternatively, self-reactive T cells can
undergo differentiation into Treg cells, which are required for the prevention of
spontaneous autoimmunity (Hsieh et al., 2012a; Josefowicz et al., 2012; Wing and
Sakaguchi, 2010). Because both of these thymic tolerance mechanisms are driven via
TCR signaling, the display of self-antigen on medullary APCs is crucial for the education
of a self-tolerant T cell population (Klein et al., 2014).
The process of generating and presenting a diverse array of self-antigens is
remarkable for its complexity. In contrast to the involvement of a single APC type for
positive selection in the thymic cortex, multiple APC types contribute to T cell tolerance
in the medulla (Anderson and Su, 2011; Derbinski and Kyewski, 2010; Klein et al.,
2014). Broadly, medullary APCs are classified as being of epithelial origin (e.g. mTECs),
or of BM origin. Their role in tolerance is supported by two key observations. First,
genetic deletion or knockdown of MHCII expression in either BM cells or mTECs
increases the total number of CD4SP thymocytes, suggesting that both APC types are
involved in deletion (Bonasio et al., 2006; Hinterberger et al., 2010; Ohnmacht et al.,
2009). However, changes in cell numbers may also reflect differences in cell survival,
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cytokine niches, and/or the rate of thymic egress (Hinterberger et al., 2011; Lio et al.,
2010). Second, TCR transgenic studies reveal that both mTECs and BM APCs are
capable of inducing Treg cells and negative selection upon presentation of cognate
antigens expressed via a second transgene (Atibalentja et al., 2011; Cowan et al., 2013;
Hinterberger et al., 2010; Proietto et al., 2008b; Román et al., 2010). However,
restricting TCR:peptide/MHC interactions to single specificities may not be
representative of the naturally occurring T cell population or developmental niche. While
these results highlight potential roles for these APC types, they do not quantify the
impact of BM APCs and mTECs on the processes of clonal deletion and Treg cell
selection (Klein et al., 2014).
Medullary tolerance is further complicated by the requirement of mTEC
production of PTAs to maintain self-tolerance. Aire has been shown to induce the
ectopic expression of PTAs in mTECs (Mathis and Benoist, 2009a; Metzger and
Anderson, 2011). Despite the importance of Aire in facilitating negative selection (Liston
et al., 2003), its role in Treg cell development is controversial. One TCR repertoire
analysis suggests that Aire has little effect on Treg cell selection (Daniely et al., 2010),
which is consistent with the observation that Aire-deficient mice have normal Treg cell
numbers (Anderson et al., 2005). However, these findings are contrary to a recent study
showing that Aire is required for thymic Treg cell selection of two TCR transgenic lines
specific to endogenous prostate-specific antigen (Malchow et al., 2013), as well as
studies of TCR:cognate antigen transgenic models. As the differences in methodologies
and conclusions cannot be easily resolved, the role of Aire in thymic Treg cell selection
remains unclear.
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Interestingly, T cell tolerance may also require the interaction of mTECs and BM
APCs for presentation of PTAs. Although Aire-dependent antigens can be autologously
presented on mTECs via autophagy (Aschenbrenner et al., 2007; Hinterberger et al.,
2010; Liston et al., 2003), mTECs can also transfer antigens to BM APC for
presentation (Aschenbrenner et al., 2007; Gallegos and Bevan, 2004; Hubert et al.,
2011; Taniguchi et al., 2012). Antigen transfer may therefore blur the distinction
between antigens that are displayed on BM APCs and mTECs. Because this has only
been addressed using TCR transgenic or MHC tetramer studies (Gallegos and Bevan,
2004; Hubert et al., 2011; Koble and Kyewski, 2009a; Taniguchi et al., 2012), the
importance of the antigen transfer pathway versus autologous mTEC antigen
presentation in mediating Aire-dependent tolerance remains unknown.
To systematically characterize the role of Aire and antigen presentation by BM APCs
and mTECs at a TCR clonal level, we used a fixed TCR model to analyze the thymic
TCR repertoires that arise upon blockade of antigen presentation on BM APCs or
mTECs, and compared them to TCR repertoires that arise in the context of Airedeficiency. Our results demonstrate that BM APCs and mTECs play non-redundant
roles in deletion and Treg cell selection, and unexpectedly reveal that a major pathway
of Aire-dependent tolerance is mediated by antigen transfer from mTECs to Batf3dependent CD8+ DCs.
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Materials and Methods
Mice
All experiments involving mice were performed using protocols approved by the
Washington University Animal Studies Committee. Mice were on a C57BL/6 genetic
background. Animals were housed and bred in a specific pathogen-free animal facility.
TCli mice (Wong, et al., 2000) and Batf3–/– (Hildner et al., 2008) mice, have been
previously described. CLEC4C-HBEGF (BDCA2-DTR) mice were a gift from M.
Colonna (WUSTL); CD11c-cre x ROSA-DTA; C2TAkd mice from L. Klein (LMU
Munich); -actin-GFP from M. Miller (WUSTL); and Foxp3gfp mice from A. Rudensky
(MSKCC). MHCII-deficient (Stock# 003239), Aire–/– (Stock# 004743), Rag1–/– (Stock#
002216), and Foxp3IRES-GFP (Stock# 006772) mice were purchased from The Jackson
Laboratory. Animals were typically 6-8 weeks old at the time experiments were
performed.

Reagents, antibodies and flow cytometry
Fluorescently conjugated antibodies were purchased from Biolegend, eBioscience, and
Becton Dickenson. Y-Ae anti-I-Ab:E peptide was obtained from Affymetrix. Samples
were analyzed using a FACSAria (Becton Dickinson) and data were processed with
FlowJo (Treestar).

Thymic dendritic cell isolation
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Based on (Hildner et al., 2008), whole thymus was mechanically separated with
scissors and digested with Liberase (125 g/ml, Roche) and DNase I (50 g/ml, New
England Biolabs) in DMEM for 30 min at 37°C.

TCR sequencing
Synthesis of TCR cDNAs from purified T cells was performed as described (Hsieh, et
al., 2006). PCR was performed using a forward primer containing the GS FLX Titanium
Amplicon Primer A sequence followed by sequence directed against TRAV14 (italics)
5’- CGTATCGCCTCCCTCGCGCCATCAG ATGGACAAGATCCTGACAGC - 3'. The
reverse primer contained the GS FLX Titanium Primer B, followed by the 12 bp error
correcting ("Golay") barcode (Ns) (Fierer et al., 2008) and a sequence complementary
to C alpha (italics), 5’- CTATGCGCCTTGCCAGCCCGCTCAG NNNNNNNNNNNN
ACACAGCAGGTTCTGGGTTC. The ~500 bp amplicons were quantified using Qubit
(Invitrogen) and pooled in equimolar ratios for emulsion PCR and 454 pyrosequencing
(Titanium chemistry). Pyrosequencer reads were demultiplexed by sample and
analyzed to determine the CDR3 sequence. Briefly, we used a custom BLAST database
of V- and J- sequences (acquired from IMGT) (Giudicelli et al., 2006) to determine the
boundaries of the V and J regions to identify the CDR3 amino acid sequence. Raw
sequence data can be found in the European Nucleotide Archive (accession #
PRJEB6458).

Assessment of thymic Treg cell selection in vivo
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As described previously (Lathrop, et al., 2011), TCR chains of interest were cloned
into the TCR-P2A-TCli retroviral vector. Foxp3IRES-GFP Rag1–/– thymocytes were
transduced with TCRs in vitro, injected intrathymically into sublethally (600 rad)
irradiated mice, and analyzed approximately 2.5 weeks later. In many experiments,
thymocytes were transduced with TCR vector containing an IRES-Thy1.1 marker, and
mixed with thymocytes transduced with a TCR vector lacking Thy1.1 prior to injection.

Bone marrow chimeras
BM was obtained by flushing donor humerus, tibia, and femur. After RBC lysis, 5x10 6
cells were injected into 1000 rad lethally irradiated host mice.

Statistical analysis
Graphpad Prism v6, SPSS v21, and R v3.0.2 were used for used for statistical and
graphical analysis. The Mann-Whitney U (MWU) test was used for between-subjects
analyses. PCA and k means clustering were performed to analyze individual-group
relationships. Morisita-Horn indices estimate species similarity between data sets.
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Results
Both BM APCs and mTECs mediate negative selection
Because the great diversity in polyclonal T cells precludes experimental analysis
at the individual TCR level, we and others have utilized mice in which TCR diversity is
limited by a transgenic fixed TCR chain (Hsieh et al., 2004; Pacholczyk et al., 2007;
Wong et al., 2007). This allows high throughput analysis of the TCR repertoire at the
individual TCR level via sequencing of the variable TCR chains. To assess the role of
MHC II presentation by BM APCs, TCli TCR transgenic Foxp3gfp Tcra+/– MHC II
deficient mice were used as BM donors into irradiated wild-type (WT) mice. To assess
the role of mTECs, TCli Foxp3gfp Tcra+/– BM was transplanted into irradiated C2TAkd
mice, in which MHC II expression is markedly reduced in mTECs owing to expression of
an shRNA to CIITA driven by the Aire promoter (Hinterberger et al., 2010).
Within the CD4SP subset, we sorted Foxp3+ Treg cells and Foxp3– CD24lo
CD62Lhi mature Tconv and sequenced their TRAV14 (V2) chains (Figure 2.1A). To
allow for statistical comparisons of TCR frequencies between conditions, the
pyrosequencing data were filtered to include those reads present in more than one third
of mice in at least one condition, and those present >0.01% in at least one mouse
(Figure 2.1B). We then plotted the average percentage of each TCR in the MHC
manipulated versus WT conditions. In the Tconv repertoire, many TCRs were
significantly enriched in MHC II-deficient BM APCs compared with MHC II-sufficient BM
APCs (Figure 2.2A, data points found below reference line of MHC II deficient BM plot).
By contrast, fewer TCRs were enriched when MHC II was reduced on mTECs (Figure
2.2A, C2TAkd).
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We classified TCRs as negatively selected based on an arbitrary >5 fold increase
in frequency and statistical significance versus the WT condition. Using these criteria,
BM APCs negatively selected approximately 25% of the TCR clones (Figure 2.2B, top),
representing ~30% of the Tconv cell population (Figure 2.2B, bottom). While a
quantitative comparison of negative selection between BM APCs and mTECs was
limited due to differences in the degree of MHC II reduction achieved experimentally,
the TCR repertoire analysis suggested that both BM APCs and mTECs are capable of
mediating negative selection.
Principal component analyses (PCA) were performed to further explore the clonal
relationship between Tconv TCRs from various backgrounds (Figure 2.2C). Analysis of
MHC II deficient BM APCs versus WT data sets revealed two distinct clusters
representing TCRs negatively selected on BM APCs (red arrow) and unaffected TCRs
(black arrow). Analysis of C2TAkd versus WT data sets showed a three factor structure
representing TCRs negatively selected on mTECs (red arrow), unaffected TCRs (black
arrow), and TCRs de-enriched by C2TAkd (blue arrow) that corresponded to the group
of TCRs in Figure 2.2A (data points found above reference line, left panel). It is unclear
why Aire-driven C2TAkd leads to a loss of Tconv TCR specificities. One possibility is
that these TCRs are simply the result of stochastic mouse-to-mouse variability.
However, these TCRs show statistical significance by nonparametric tests and
clustering by PCA, suggesting that this is unlikely. Another untested possibility is that
C2TAkd inhibits the positive selection of these particular Tconv TCRs. Because our
primary goal was to study the role of APC subsets in tolerance, we focused our analysis
on TCRs affected by deletion and Treg cell selection.
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We observed negative selection of the Treg repertoire by both mTECs and BM
APCs (Figure 2.3A). Several TCRs were significantly enriched when MHC II was
deleted from BM APCs (red dots found below the reference line), a phenomenon that
was less pronounced with mTECs. Treg TCRs classified as negatively selected by BM
APCs represent approximately 35% of TCR clones, which accounted for ~30% of the
Treg cell population (Figure 2.3B). PCA analysis revealed a cluster of TCRs associated
with negative selection (red arrows) by BM APCs, but not mTECs (Figure 2.3C).
Together with the Tconv analysis, these data demonstrate that ablation of MHC II on
BM APCs has a marked effect on the negative selection of a diverse array of both Treg
and Tconv cell TCRs, estimated to comprise ~30% of the analyzed TCR repertoire.
The results of this TCR repertoire analysis implied that certain TCRs instruct
developing Tconv and Treg cells to undergo negative selection. For example, TCR
clone NS1 is rare in the normal Treg TCR repertoire, but common when MHC II is
deficient in BM APCs (Figure 2.4 & 2.5A). To demonstrate the functional role of TCRs in
instructing cell-fate decisions in vivo, we used a retroviral vector to express NS1 in
Rag1–/– thymocytes, and injected them into the thymi of chimeras with selective MHC II
deficiency in either mTECs or BM APCs (Figure 2.4). CD4SP cells were readily
observed when MHC II was absent from BM APCs (~20%, Figure 2D), a portion of
which were Foxp3+ (data not shown). Similar results were obtained with another TCR,
NS3 (Figure 2.5B). Thus, these in vivo results provide independent validation for the
TCR repertoire analysis showing negative selection by BM APCs.

BM APCs and mTECs select non-redundant thymic Treg cell pools
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In conjunction with the enrichment of certain Treg cell TCRs with MHC II ablation
on BM APCs, there was also a loss of distinct TCRs from the Treg cell repertoire
(Figure 2.3A, red dots above reference line). As Treg cell differentiation is driven by selfrecognition, the decrease in frequency of certain TCRs would be consistent with the
loss of Treg cell selection mediated by BM APC antigen presentation (Figure 2.3B).
While the diminished MHC II expression on mTECs affected the negative selection of a
small number of Tconv and Treg cell TCRs, it led to a decrease in the frequency of
many more Treg cell TCRs (Figure 2.3A, data points above reference line in the left
panel). The effect of MHC II-deficiency in BM APCs on the Treg cell population as a
whole was much greater than the effect of C2TAkd on mTECs suggesting that BM
APCs facilitate Treg cell selection of more frequent Treg cell TCRs (~60% compared to
~20%, Figure 2.3B). PCA analysis confirmed that a cluster of TCRs associated with
Treg cell selection (blue arrow) was present in both MHC II deficient BM and C2TAkd
mTEC conditions (Figure 2.3C). These results suggest that both APC types are directly
involved in Treg cell selection.
BM APCs and mTECs presumably present distinct arrays of antigens related to
different mechanisms of antigen processing and presentation, as well as different
transcriptional landscapes partially attributable to the expression of Aire in mTECs.
However, antigen transfer from mTECs to BM APCs may blur the distinction between
antigens that are specific to mTECs or BM APCs. We therefore asked whether the TCR
repertoires selected by BM APCs versus mTECs were similar. Consistent with the
estimated effect on the Treg cell TCR repertoire (Figure 2.3B), the Morisita-Horn index
showed dissimilarity between the Treg cell TCR repertoires of MHC II deficient versus
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WT BM conditions (Figure 2.6A). The Treg cell TCR repertoire selected by BM APCs
was also quite different than that selected by mTECs (~0.1, Morisita-Horn index, Figure
2.6B). Thus, these findings suggest that ablation of MHC II on BM cells has more
profound effects on the Treg cell population than does silencing of MHC II on mTECs.
The difference in the Treg cell TCR repertoire suggested by global analysis
could also be visualized upon inspection of the 15 most frequent Treg cell TCRs in WT
mice (Figure 2.6C). There was a marked reduction of 10 TCRs in MHCII deficient BM
APCs, including the top 3 most frequent TCRs, often with concomitant increase in the
Tconv cell subset (Figure 2.7). By contrast, only 6 of the 15 most frequent TCRs were
decreased with silenced MHCII in mTECs.
Despite the involvement of mTECs in selecting Treg cells with certain TCR
specificities (Figure 2.3A-C), Morisita-Horn analysis of the Treg cell TCR repertoires
between C2TAkd and WT showed high similarity (Figure 2.6A). A follow-up assessment
of the top 15 C2TAkd Treg TCRs revealed that the top 3 most frequent TCRs are also
the top 3 most frequent Treg cell TCRs in the WT (Figure 2.8A), which was not the case
with BM APCs (Figure 2.6C). Because the Morisita-Horn similarity index is abundance
weighted, we asked whether successive removal of these TCRs from the analysis
would alter this similarity. Indeed, removal of the top 3 TCRs suggested that, similar to
BM APCs, mTECs do select a substantial portion of the Treg cell TCR repertoire, albeit
less frequent Treg cell TCRs (Figure 2.8B). As independent validation, retroviral
expression of mTEC-dependent Treg cell TCRs confirmed that MHC II presentation by
mTECs was important for Treg cell selection (Figure 2.8C, 2.9). These results suggest
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that a substantial portion of the Treg cell repertoire is selected via antigen presentation
by mTECs.

DCs are the primary BM APC subset involved in Treg cell selection
Because BM APCs consist of multiple populations capable of antigen
presentation, we next sought to identify the population mediating Treg cell selection. To
do so, we used mice in which conventional DCs are constitutively deleted via a CD11ccre transgene that activates diphtheria toxin conditionally expressed under the control of
the ROSA locus (Ohnmacht et al., 2009). Thymocytes with retroviral expression of the
top four WT Treg cell TCRs (G25, G69, G41, R19) showed poor Treg cell development
in CD11c-cre ROSA-DTA mice in comparison with WT or C2TAkd mice (Figure 2.9). By
contrast, the mTEC-dependent TCR G126 showed normal Treg cell selection in WT and
CD11c-cre ROSA-DTA mice, but not in C2TAkd mice (Figure 2.9). These findings
suggest that conventional DCs are the primary BM-derived APC subset that mediates
thymic Treg cell selection.

Aire is required for selection of a subpopulation of thymic Treg cells
An important feature of mTECs is their expression of Aire, a gene responsible for
promiscuous expression of tissue specific antigens (Anderson and Su, 2011; Mathis
and Benoist, 2009a). The role of Aire in Treg cell selection has been controversial
(Anderson et al., 2005; Daniely et al., 2010; Malchow et al., 2013). Therefore, we
assessed the TCR repertoire of Aire–/– mice with a TCli transgene. We found that a
number of Tconv and Treg cell TCRs were enriched in Aire–/– compared to isogenic
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Aire+/+ mice (Figure 2.10A, B), suggesting that Aire plays a role in negative selection of
both Tconv and Treg cells.
We also observed that a number of Treg cell TCRs were significantly diminished
in frequency in Aire–/– mice, consistent with Aire-dependent Treg cell selection (Figure
2.10A, C). This contrasted with the high degree of similarity between Aire-deficient and -sufficient Treg TCR repertoires based on the Morisita-Horn similarity index. However,
we found that this was based primarily on the top three TCRs, as their removal
markedly lowered the Morisita-Horn similarity values (Figure 2.11A), consistent with an
effect of Aire on lower frequency TCRs. Thus, depending on whether the analytic
approach favors more abundant TCRs or assesses them at an individual TCR level,
Aire may be viewed as having no effect to having a significant effect on Treg cell
selection, potentially explaining previously conflicting studies on the role of Aire in Treg
cell selection (Daniely et al., 2010; Malchow et al., 2013).
Because Aire is exclusively expressed in TECs in the thymus, we asked whether
Aire-dependent TCRs were selected via antigen presentation by mTECs. Consistent
with this hypothesis, Morisita-Horn analysis indicated that the Aire-deficient Treg cell
TCR repertoire was quite similar to the C2TAkd repertoire (~ 0.8) but not to the MHC II
deficient BM Treg TCR repertoire (~0.35). However, upon removal of the top 3 TCRs
from the analysis, the Aire-deficient Treg cell TCR repertoire was much less similar to
the C2TAkd repertoire (~0.5) and equivalently similar to the MHC II deficient BM
repertoire (~0.5, Figure 2.11B), consistent with a role for Aire in selecting lower
frequency Treg cell TCRs. Cross-referencing the list of Treg cell TCRs that were Airedependent with those that were BM APC- or mTEC-dependent confirmed the
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substantial role of both BM APCs and mTECs in mediating Aire-dependent central
tolerance (Figure 2.10B,C). This can also be visualized in the analysis of the top 15
Treg cell TCRs found in WT condition (Figure 2.11B). Of the 7 TCRs that were Airedependent (G25, G41, G126, R25, R35, JP13, R117), 4 were also dependent on BM
APCs (G25, G41, R35, R117) and 2 on mTECs (G126, R25). These findings suggest
that the presentation of Aire-dependent antigens by BM APCs plays a major role in
central tolerance.
To independently confirm these sequencing analyses, we used retrovirus to
express Aire-dependent Treg TCRs in Rag1–/– thymocytes and then assessed Foxp3+
Treg cell development in Aire-deficient or -sufficient hosts. The in vivo behavior of six
Aire-dependent and five Aire-independent Treg cell TCRs recapitulated the patterns
observed via TCR sequencing (2.11C, D). This sample set of Treg cell TCRs also
included those dependent on MHC II presentation by CD11c+ DCs or mTECs as
assessed previously (Figure 2.8, 2.9), confirming the non-redundant roles of these APC
subsets in mediating the effects of Aire seen by TCR sequencing. Thus, while many
Aire-dependent Treg cell TCRs are selected in response to autologous antigen
presentation by mTECs, others are selected via antigen presentation by CD11c + DCs
that do not express Aire.
Aire has been suggested to facilitate the recruitment of DCs via production of
chemokines by mTECs (Lei et al., 2011). However, Aire-deficiency did not abrogate all
Treg cell selection by BM APCs, as six of 10 common BM-dependent Treg cell TCRs
were Aire-independent by TCR sequencing (Figure 2.11B). Moreover, four of eight BM
APC-dependent TCRs expressed on Rag1–/– thymocytes in vivo also facilitated Treg
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cell selection independent of Aire as predicted based on TCR sequencing (Figure
2.11C, D). Thus, Aire does not appear to affect Treg cell selection via a global effect on
the total thymic DC population.

Batf3-dependent CD8+ DCs preferentially acquire and present Aire-dependent
antigens to mediate Treg cell selection
BM APCs play a major role in Aire-dependent and -independent Treg cell
selection (Figure 2.10C). As there are a number of distinct cell types within the BM APC
population, we sought to identify the subset(s) relevant to Treg cell selection. Our data
using retroviral TCR expression in thymocytes suggested that the major BM APC
subset responsible for Treg cell selection were CD11c + DCs (Figure 2.9). Thymic
CD11c+ DCs can be subdivided into two primary subsets, the SIRP+ DCs and CD8+
DCs, which may be functionally redundant because they both acquire and present
blood-derived antigens (Atibalentja et al., 2011). To test whether CD8+ DCs were
necessary for Treg cell selection, we used a retroviral vector to express BM APCdependent Treg cell TCRs in Rag1–/– thymocytes and intrathymically transferred these
cells into CD8+ DC-deficient Batf3–/– hosts (Figure 2.12) (Hildner et al., 2008). We
observed that CD8+ DCs were required for four out of eight BM APC dependent TCRs
tested (Figure 2.13A). By contrast, depletion of plasmacytoid DCs in the thymus had no
effect on Treg cell selection of 4 BM APC-dependent TCRs (Figure 2.13B). We
conclude that in a polyclonal repertoire, CD8+ DCs and SIRP+ DCs play nonredundant roles in Treg cell selection.
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CD8+ DCs were required for Treg cell selection of TCRs co-dependent on Aire
and BM APCs, as all four CD8+ DC-dependent Treg cell TCRs were Aire-dependent,
whereas all 4 CD8+ DC-independent Treg cell TCRs were Aire-independent (Figure
2.11B-D; 2.13A). To assess whether our observations reflect antigen transfer from
mTECs to CD8+ DCs, we generated BM chimeras in which host cells (i.e. mTECs)
expressed GFP under the chicken beta actin promoter, and analyzed the acquisition of
GFP by congenically marked donor DCs. We found that CD8+ DCs acquired
significantly more GFP than SIRP+ DCs, consistent with antigen transfer from mTECs
to CD8+ DCs (Figure 2.13C). However, it is possible that the increased amount of GFP
in CD8+ DCs might reflect a differential ability to degrade GFP. Therefore, we tested
whether host cell-generated antigens could be presented on MHCII of donor cells by
generating BM chimeras with H-2b donors into H-2d hosts and assessing the
presentation of host derived E on donor I-Ab using the monoclonal antibody Y-Ae
(Humblet et al., 1994; Rudensky et al., 1991). Indeed, CD8+ DCs presented more E
on I-Ab than SIRP+ DCs, corroborating our hypothesis that CD8+ DCs are more
efficient at acquiring and presenting mTEC-derived antigens (Figure 2.13D). Taken
together, these findings suggest that CD8+ DCs show an enhanced ability compared
with SIRP+ DCs to acquire and present antigens from thymic epithelial cells. Thus, our
results indicate that CD8+ DCs play an important role in acquiring and presenting Airedependent antigens for thymic Treg cell development.
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Figure Legends
Figure 2.1. TCR sequencing output for MHC II-deficient, C2TAkd, and control
mice.
(A) 454 pyrosequencing of TCRs from MHC II deficient (def.) BM and C2TAkd
chimeras and the corresponding controls which are wild-type (WT) for MHC expression.
Chimeras were generated using TCli Tcra+/– (MHC II def. or WT) TCR transgenic
donors. After 6 weeks, Foxp3+ (CD4+CD8–Foxp3gfp+) and Foxp3– (CD4+CD8–
CD62LhiCD24loFoxp3gfp–) cells were sorted and the TCRs sequenced by 454
pyrosequencing. (B) Effect of filtering TCRs that are found > 0.1% in at least one mouse
in a given condition. Shown are plots of the total frequency captured by the filtered
TCRs (left) and the average frequency in a given experimental condition of the TCRs
lost by this filtering criteria in the WT  WT Treg and Tconv repertoires (right).

Figure 2.2. Both BM and mTEC APCs mediate negative selection.
(A) Changes in Tconv TCR frequency with manipulation of MHC II expression on
BM APCs or mTECs. Data shown are the frequency of Foxp3 – CD4SP TCRs in MHC II
deficient (def) BM or C2TAkd chimeras cross-referenced with their frequency in control
chimeras, which are wild-type (WT) for MHC expression. Red dots indicate TCRs that
were significantly different (p < .05) by Mann-Whitney U test. (B) Summary of effects on
the Tconv cell TCR repertoire with modulating MHC II expression on mTECs or BM
APCs. Data shown are the percentage of unique TCRs (top) or total sequences
(bottom) in the filtered data set that are negatively selected based on the following
criteria (statistically significant effect; ≥ 80% decrease in WT frequency). (C) Principal
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component analysis of the TCR frequencies. Red dots/arrow form a cluster of TCRs
(variances: MHC II def. BM = 27.5%, C2TAkd = 11.1%) that correlate with, but are not
necessarily identical to, the negatively selected TCRs in (A). Similarly, black dots/arrow
represents TCRs unaffected by deficiency of MHC II in a given APC, and blue
dots/arrow represent TCRs enriched in WT mice relative to C2TAkd mice (variance =
12.6%). Centroids represent the middle of a given cluster. A shorter line represents
greater similarity to the centroid. Data represent three independent experiments with 2-3
replicates per experiment.

Figure 2.3. Treg cell TCR sequencing of MHC II-deficient and C2TAkd mice.
(A) Changes in Treg cell TCR frequency with manipulation of MHC II expression
on BM APCs or mTECs. Similar to Figure 1A, data shown are the frequency of Foxp3 +
CD4SP TCRs in MHC II def. BM or C2TAkd chimeras cross-referenced with their
frequency in WT chimeras. Red dots indicate TCRs that were significant (p < .05) by
Mann-Whitney U test. (B) Summary of effects on the Treg cell TCR repertoire, with
modulating MHC II on mTECs or BM APCs. Data shown are the percentage of unique
TCRs (top) or total sequences (bottom) in the filtered data set that are interpreted to
undergo APC-dependent negative selection (left), or Treg cell selection (right), based on
the following criteria: statistical significance (as judged by Mann-Whitney U test) and ≥
an 80% percent change in frequency versus WT. (C) Principal component analysis of
the TCR frequencies. Like Figure 1C, red dots/arrow correlate with negatively selected
TCRs (variances: MHC II def. BM = 17.5%, C2TAkd = 11.6%), black dots/arrow
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unaffected TCRs, and blue dots/arrow Treg TCRs (variances: MHC II –/– BM = 41.6%,
C2TAkd = 28.0%).

Figure 2.4. Negative selection of an abundant BM APC-dependent Treg cell TCR.
Data represent three independent experiments with 2-3 replicates per
experiment. BM APCs negatively select TCR NS1 in vivo. Data shown are
representative flow cytometry plots (top) and summary (bottom) of intrathymic injection
of Rag1–/– thymocytes retrovirally-transduced with NS1 and transferred into WT versus
C2TAkd (left) or WT versus MHCII def. BM (right) chimeric mice (data were pooled from
at least two independent experiments with 2 replicates per experiment). Mann-Whitney
U test for significance, ***p < .001.

Figure 2.5. Negative selection of a low frequency BM APC-dependent Treg cell
TCR.
(A) Distribution of NS1 and NS3 in the TCR repertoires of WT, MHC II def. BM
and C2TAkd conditions. (B) NS3 is negatively selected by BM APCs. Representative
FACS plots of Rag1-/- thymocytes retrovirally-transduced with TCR NS3 and transferred
into the thymi of WT, MHC II def. BM and C2TAkd chimeric mice. Plots are
representative of 2 independent experiments with 1-2 replicates.

Figure 2.6. Role of BM APCs and mTECs in thymic Treg cell selection.
(A, B) Morisita-Horn similarity analysis of Treg and Tconv cell TCR repertoires.
In (A), the TCR repertoire from each MHC manipulation is compared with the WT
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repertoire, whereas in (B) the comparison is between the MHC II def. BM APC and
C2TAkd repertoires. An index value of 1 indicates that the two samples are completely
similar whereas an index value of 0 means they are completely dissimilar. (C) Analysis
of individual Treg cell TCRs from the WT condition. The top 15 individual Foxp3 +
CD4SP TCRs from aggregated WT data sets are shown sorted by frequency, along with
the corresponding frequency in the C2TAkd or MHC II def. BM Treg TCR repertoires.

Figure 2.7. Behavior of the WT Treg cell TCRs across conditions.
Amino acid sequence of the top 15 WT TCRs and their frequencies in the WT,
MHC II def. BM, and C2TAkd Treg and Tconv cell data sets.

Figure 2.8. mTEC antigen presentation is required for in vivo Treg cell selection of
certain TCRs.
(A) Analysis of individual Treg cell TCRs from C2TAkd chimeras. The top 15
Foxp3+ TCRs in the C2TAkd dataset are shown sorted by frequency, along with the
corresponding frequency in the WT and MHC II def. BM datasets. (B) Change in
Morisita-Horn index with removal of most common TCRs. Similarity between Foxp3 +
TCR repertoires of C2TAkd versus WT (left) and MHC II def. BM APC versus WT (right)
were assessed after removing the top 1, 2, or 3 highest frequency WT TCRs from the
analysis. (C) In vivo validation of Treg cell TCRs dependent on mTEC antigen
presentation. Three high frequency mTEC-dependent Treg TCRs were identified by
sequencing, including G126, a common C2TAkd Treg TCR that is reduced in frequency
in comparison with WT (Figure 3A). These TCRs were assessed for their ability to

33

facilitate Treg cell selection after transduction into Rag1-/- thymocytes, which were then
injected into the thymi of WT or C2TAkd hosts. After 2.5 weeks, donor T cells were
analyzed for Foxp3 expression by flow cytometry gating on CD45.1 + CD45.2– V2+
CD4SP cells. Data were pooled from at least two independent experiments with 2
replicates per experiment.

Figure 2.9. DCs are the primary BM APC subset involved in Treg cell selection.
The top 5 WT Treg cell TCRs, of which the top 4 are BM APC-dependent, were
retrovirally transduced into Rag1–/– thymocytes and then intrathymically injected into
WT, CD11c-Cre ROSA-DTA, or C2TAkd hosts. Data shown are representative flow
cytometry plots (left) and summary graphs (right) with each dot representing the data
from one host. Each TCR was analyzed in at least 2 independent experiments with 2-3
replicates. Mann-Whitney U test for significance, **p < .01, ***p < .001, ns = not
significant.

Figure 2.10. Role of Aire in Tconv and Treg cell selection and deletion.
(A) Changes in TCR frequency with Aire. The frequencies of Foxp3 – (top panel)
and Foxp3+ (bottom panel) TCRs in WT and Aire–/– mice are plotted as per Figure 1A
and 2A. Red dots indicate TCRs that are significantly different by Mann-Whitney U (p <
.05). (B, C) Summary of the effects of Aire on the TCR repertoire. Data shown are the
percentage of unique TCRs (top) or total sequences (bottom) interpreted to undergo
Aire-dependent negative selection (B) or Treg cell selection (C), as described in Figures
1B and 2C.
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Figure 2.11. Aire-dependent Treg cell selection is mediated through both mTECand BM APC-dependent pathways.
(A) Morisita-Horn similarity analysis of Treg cell TCR repertoires from Aire–/–
versus WT mice (top), or MHC II def. BM (bottom) or C2TAkd (middle), with leave-oneout analysis as per Figure 3B removing the top 1, 2, or 3 highest frequency Aire–/–
TCRs. (B) Analysis of the top 15 WT Treg cell TCRs for their dependence on BM APCs,
mTECs, and Aire. The heatmap shows the effect of an indicated experimental condition
on an individual TCR (% of TCR in condition / [% in WT + % in condition]). Values < 0.5
indicate a loss of the TCR in the condition (green color), implying that the Treg cell TCR
is dependent on the condition. Red represents values > 0.5 indicating enrichment of
TCR in condition relative to WT, suggestive of negative selection. (C) In vivo analysis of
BM APC and mTEC dependent Treg cell TCRs. Treg cell differentiation in response to
Aire was assessed using Rag1–/– thymocytes transduced with retrovirus expressed Treg
cell TCRs showing varying dependence on Aire, BM APCs, and mTECs by TCR
repertoire analysis. Each dot represents data from a single host. Mann-Whitney U test,
***p < .001. (D) Representative FACS plots of (C). Data are representative of at least 2
independent experiments with 1-3 replicates per experiment.

Figure 2.12. Deletion of CD8+ DCs in Batf3–/– mice.
FACS plots of CD8+ and SIRP+ DCs from the thymi of Batf3+/– or Batf3–/– mice.
Plots are representative of 4 replicates.
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Figure 2. 13. CD8+ DCs preferentially acquire and present Aire-dependent
antigens to developing Treg cells.
(A) In vivo analysis of the role of CD8+ DCs in Treg selection of TCRs that are
dependent on both BM APC and Aire. Rag1–/– thymocytes expressing TCRs were
injected into the thymi of Batf3–/– or WT hosts. (B) Plasmacytoid DCs are not required
for Treg cell differentiation of Aire and BM APC co-dependent Treg TCRs. As per (A),
except the Treg TCRs were tested in BDCA2DTR mice treated with diphtheria toxin (120
ng/mouse) or PBS. (C) Protein transfer from radioresistent host thymic cells to CD8+
and SIRP+ DCs. BM chimeras of Ly5.1 (donor) into Actin-GFP (host) mice were
harvested after 4 weeks. Thymi were digested and the presence of host-derived GFP in
donor DCs was assessed. Representative flow cytometry histogram overlays and
pooled data are shown. (D) Antigen transfer from radio-resistant thymic epithelial cells
to CD8+ DCs. BM chimeras of Ly5.1 H-2b (donor) into H-2d (host) mice were harvested
after 4 weeks. The presence of host-derived E 52-68 peptide bound to I-Ab on donor
DCs was assessed using the Y-Ae antibody. Mann-Whitney U test for significance, *p <
.05, **p < .01, ***p < .001, ns = not significant. Plots shown are pooled data from at least
two experiments with 1-3 replicates per experiment. Each dot represents data from an
individual host.
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Figure 2 7. Behavior of the WT Treg cell TCRs across conditions.
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Figure 2 12. Deletion of CD8+ DCs in Batf3–/– mice.
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Discussion
Thymocyte encounter with self-antigen in the thymic medulla is crucial for the
generation of self-tolerance – a process notable for its involvement of a myriad of APCs
and transcription factors. Although previous work has suggested contributions of each
APC subset and Aire to T cell tolerance at a population level, it remained unclear if
these components functioned uniquely or redundantly. Here, we made several
observations regarding CD4+ T cell tolerance by analyzing TCR repertoires in a fixed
TCR model. First, mTECs and BM APCs make non-redundant contributions to deletion
and Treg cell selection, suggesting that each APC subset differs in the self-antigens that
they functionally display. Within the BM APC population, CD11c + DCs were the primary
subset involved in Treg cell selection. Second, Aire expression in mTECs affected both
deletion and Treg cell selection. However, Aire had a greater impact on lower frequency
TCRs, which may explain previous conflicting reports depending on whether the
analysis favored more global versus individual T cell clonal assessments. Third, the
presentation of antigens induced by Aire occurred by both BM APCs and mTECs.
Because Aire is not expressed in BM cells, this implies that antigen transfer is a major
mechanism involved in Aire-dependent tolerance. Finally, of the thymic DC subsets,
Batf3-dependent CD8+ DCs were primarily responsible for taking up Aire-dependent
antigens from mTECs for inducing Treg cell selection. Thus, these data reveal a
remarkable complexity and interdependence between Aire and the medullary APC
subsets.
The extent of negative selection by BM APCs and mTECs estimated by our TCR
repertoire analysis is within range of previous estimates. For example, it has been
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suggested that BM APCs may delete up to half of the positively selected CD4 + T cell
population based on the observation that chimeras with MHC II deficient BM donors had
anywhere from 50% (Hinterberger et al., 2010) to 70% (van Meerwijk et al., 1997)
greater CD4SP cell numbers. Similar results were reported for genetic depletion of DCs
(Ohnmacht et al., 2009) and deletion of MHC II on DCs (Liston et al., 2008). However, a
recent report by Hogquist et al incorporating mathematical modeling suggests that only
~10% of CD4SP cells undergo negative selection in total (Sawicka, 2014). For mTECmediated negative selection, it was reported that C2TAkd mice have an increase of
~20% in CD4SP cells, and ~46% in Treg cells (Hinterberger et al., 2010).
Our TCR repertoire analysis suggested that around ~30% and ~10% of the
CD4SP population were negatively selected by BM APCs and mTECs, respectively.
This is based primarily on our estimates of negative selection in Tconv cells, as
negatively selected Treg cells are 1/10 th in number. Potential differences between these
various estimates could arise from the different analytic approaches. For example,
extrapolating negative selection from changes in CD4SP cell numbers may not account
for differences in cell survival, proliferation, or emigration. Additionally, our use of a fixed
TCR chain may not entirely reflect the WT TCR repertoire. However, data from
previous groups using limited repertoire models have generally been consistent (Hsieh
et al., 2004; Pacholczyk et al., 2007; Wong et al., 2007), albeit sometimes with different
interpretations (Hsieh et al., 2012a; Klein et al., 2014). The use of MHC II deficient BM
APCs does not exclude the possibility that they may be able to acquire intact MHC II
from mTECs. Finally, the use of C2TAkd may underestimate the contribution of mTECs
as the blockade of MHC II synthesis is incomplete (Hinterberger et al., 2010). While
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further studies are required to resolve these quantitative differences, our data support
the pre-existing notion that BM APCs, and to a lesser extent mTECs, both play
important and non-redundant roles in the negative selection of a substantial number of
TCR clones.
By contrast, our TCR repertoire analysis revealed a major alteration in Treg cell
selection imparted by BM APCs, which was unexpected based on current studies.
Previously, it was suggested that BM APCs were not required for Treg cell selection as
normal Treg cell frequencies or numbers occurred with expression of MHC II only on
thymic cortical epithelial cells (Bensinger et al., 2001) or with ablation of MHC II on DCs
(Hinterberger et al., 2010; Liston et al., 2008). Our TCR repertoire analysis suggests
that BM APCs alter the composition of the thymic Treg cell repertoire without changing
overall Treg cell numbers by facilitating both the addition and removal of TCR clones
from the Treg cell population.
Our data may help resolve an ongoing controversy regarding the role of Aire in
Treg cell selection. Some have argued against a role for Aire in Treg cell selection
based on normal polyclonal Treg cell numbers (Anderson et al., 2005) and minimal
change in the global TCR repertoire in a limited TCR repertoire model (Pacholczyk et
al., 2007). Others have reported that there are differences in Treg cell numbers in Airedeficient mice (Lei et al., 2011), and that two TCR transgenic lines were dependent on
Aire for thymic Treg cell selection (Malchow et al., 2013). Our TCR repertoire analysis
suggests that Aire affects both Treg cell selection and deletion. However, because Aire
more commonly affects lower frequency TCRs, its effect is likely masked when

52

analyzing bulk Treg cell numbers or TCR repertoire similarity using abundance
weighted assessments.
In addition to addressing the role of Aire on Treg cell selection, we quantified the
antigen presentation requirements for Aire by cross-referencing sequences from Aire
and APC data sets. Our observation of mTEC and Aire co-dependent Treg cell TCRs is
consistent with recent studies showing that antigens expressed in mTECs can be
autologously presented via an autophagy-dependent pathway (Aichinger et al., 2013b;
Nedjic et al., 2008a). Unexpectedly, we also found that many Aire-dependent Treg cell
TCRs were dependent on BM APCs. Because Aire is not expressed in BM APCs, our
findings suggest that mTEC antigens are transferred to BM APCs, a phenomenon that
has been observed at the level of individual antigens using TCR transgenic models or
MHC II tetramers (Gallegos and Bevan, 2004; Hubert et al., 2011; Koble and Kyewski,
2009a; Taniguchi et al., 2012). Our data suggests that the process of antigen-transfer is
quite common, being involved in approximately 50% of Aire-dependent deletion and
Treg cell selection.
Because the TCR repertoire studies were performed at the level of individual
TCRs, we were able to utilize sequencing results to isolate representative TCRs to
further interrogate the BM APC population involved in the transfer and presentation of
Aire-dependent antigens. Our in vivo analysis of TCRs that were co-dependent on BM
APC and Aire revealed that CD8+ DCs were required for antigen transfer-mediated
Treg cell selection. Consistent with this, we found that CD8+ DCs were more efficient
at acquiring I-E and the neo-self antigen GFP from thymic stromal cells than SIRP+
DCs. Although previous work demonstrates that CD8+ and SIRP+ DCs equivalently
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present blood-derived antigens (Atibalentja et al., 2011), our results suggest that CD8+
DCs may have additional properties that facilitate antigen transfer from mTECs. One
such property may be the expression of the chemokine receptor XCR1 by thymic CD8+
DCs, which recognizes XCL1 produced by mTECs in an Aire-dependent manner (Lei et
al., 2011) and could facilitate DC:mTEC interactions. Taken together, these data
suggest that Batf3-dependent CD8+ DCs are the primary BM APC subset responsible
for antigen transfer-mediated Treg cell selection of Aire-dependent antigens.
Batf3-deficiency was previously reported to result in the loss of the CD8+ DC
subset by phenotypic markers and functional assays in the periphery (Hildner et al.,
2008). Similarly, we observed functional deficiencies in the selection of certain Treg
TCR clones associated with loss of phenotypic CD8+ DCs. However, our data cannot
definitively exclude the possibility that DCs in the CD8+ lineage remain with altered
function and cell-surface phenotype in Batf3 deficient mice. It is worth noting that the
difference in CD8+ and SIRP+ DCs in presenting mTEC derived antigens may be
quantitative, as we did see antigen transfer occur with both DC subsets. Further studies
will be required to address the role of SIRP+ DCs in T cell selection at the clonal level.
Another distinct property of CD8+ DCs is that they are much more efficient at
cross-presenting exogenous antigens onto MHC I than other DC subsets (Hildner et al.,
2008; Joffre et al., 2012; Proietto et al., 2008a). It is notable that thymic deletion of MHC
I restricted T cells has also been shown to occur via antigen transfer to BM APCs
(Gallegos and Bevan, 2004; Hubert et al., 2011). Thus, we speculate that the ability to
cross-present would allow CD8+ DCs to efficiently educate both CD4+ and CD8+ T
cells to self-antigens acquired from Aire-expressing mTECs.
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If CD8+ DCs play an important role in Treg cell selection, why has spontaneous
autoimmunity not been reported for Batf3–/– mice? In this regard, it is interesting to note
that immunopathology is reportedly mild in Aire–/– mice on the same C57BL/6
background as the mice in our study (Hubert et al., 2009). For Batf3–/– mice, an
additional possibility is that CD8+ DCs are required both for selection in the thymus
and activation of the same TCR specificities in the periphery (Klein et al., 2014). Future
studies are required to address these possibilities.
In summary, our analysis of a fixed TCR repertoire provides insights into how
medullary APCs and Aire educate the developing T cell population. We have shown that
both mTECs and BM APCs make non-overlapping contributions to thymic deletion and
Treg cell selection to shape the mature CD4 + T cell population, and that Aire-mediates
its effects via both BM and mTEC antigen presentation. Furthermore, we have
demonstrated that of the BM APCs, CD8+ DCs primarily acquire and present Airedependent antigens to developing Treg cells. However, it remains unclear why certain
Aire-dependent TCRs undergo Treg cell selection on mTECs and others on BM APCs.
Is it because some antigens are more readily loaded onto MHC II via macroautophagy
for autologous presentation on mTECs, whereas other antigens are not? Are there
specific features of Aire-dependent antigens such as cell surface association that favor
transfer to CD8+ DCs? Thus, future experiments are required to understand the
mechanistic and functional rationale for the transfer of Aire-dependent antigens from
mTECs to CD8+ DCs in mediating central tolerance.
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CHAPTER 3
Necessity of antigen transfer from Aire-dependent mTECs to CD8+ DCs for T
cell tolerance
The results in this chapter describing the role of CD8+ DCs for thymic T cell
tolerance are adopted from a manuscript submitted for publication.

Abstract
Generation of T cell tolerance is mediated in part through cooperative antigen
presentation between bone marrow and mTECs in the thymus. However, the
mechanisms by which this occurs remain unknown. Here, we show that Batf3dependent CD8+ DCs facilitate thymic tolerance via negative selection and Treg cell
generation to antigens dependent on Aire expressed in mTECs. This tolerance is
mediated in part by CD36, a scavenger receptor preferentially expressed by CD8+
DCs. Notably, CD36 is important for acquisition of cell-surface, but not cytoplasmic,
antigens from mTECs. These transferred antigens are likely displayed on the cell
surface, as thymocytes from Batf3- or CD36-deficient donors are not tolerant to host
MHC after allogenic bone marrow transplantation. Thus, these data suggest that CD36
mediates the “cross-dressing” of mTEC-derived cell-surface antigens to facilitate
tolerance to self-antigens as well as allo-antigens during bone marrow transplantation.
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Introduction
During T cell ontogeny, TCR gene segments are rearranged to generate a
diverse TCR repertoire necessary for immunity to invading pathogens (Klein et al.,
2014; Vrisekoop et al., 2014; Weissler and Caton, 2014). A consequence of this
diversity is the recognition of self-antigen and the potential for autoimmunity. For T cells,
two primary processes generate tolerance to self in the thymus (a.k.a. central tolerance)
prior to their release into the periphery: negative selection of autoreactive TCR clones,
and the generation of Treg cells (Bluestone et al., 2015; Klein et al., 2014; Li and
Zheng, 2015; Richards et al., 2016). Both processes are driven by TCR recognition of
self-antigens presented by APCs. Although this can occur throughout the thymus, it
commonly occurs in the thymic medulla and involves both mTECs and BM-derived DCs,
B cells, and macrophages (Chan and Anderson, 2015; Klein et al., 2014; Oh and Shin,
2015). Thus, a diverse array of medullary APCs is involved in thymic T cell tolerance.
The mTEC population is notable for its expression of the Autoimmune Regulator
(Aire), which plays an important role in mTEC development, thymic architecture, and the
ectopic expression of PTAs in the thymus (Chan and Anderson, 2015). mTECs can
tolerize T cells to these PTAs via non-conventional cell-autonomous antigen
presentation (Aichinger et al., 2013b; Aschenbrenner et al., 2007; Cowan et al., 2013;
Hinterberger et al., 2010; Oukka et al., 1996; Perry et al., 2014). It has become
increasingly clear, however, that an equally important mechanism of thymic tolerance to
Aire-dependent antigens involves transfer of mTEC antigens to BM APCs (Gallegos and
Bevan, 2004; Hubert et al., 2011; Koble and Kyewski, 2009a; Lin et al., 2016; Millet et
al., 2008; Perry et al., 2014).
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Recently, we proposed that CD8+ DCs may be the primary BM APC recipient of
antigen transferred from mTECs (Perry et al., 2014). This is consistent with previous
observations showing that XCR1-expressing CD8+ DCs home to mTEC-rich regions of
the medulla due to mTEC-derived chemokine XCL1 (Atibalentja et al., 2011; Baba et al.,
2009b; Klein et al., 2014; Lei et al., 2011). Our conclusion was based on an in vivo
developmental assessment of 8 Treg cell TCRs dependent on MHC II expression on
BM APCs, of which 4 TCRs were co-dependent on Aire. All 4 of the BM and Aire-codependent TCRs required CD8+ DCs for Treg cell development, suggesting that this
DC subset is an important component of cooperative antigen presentation of mTEC
antigens. While these data with individual TCRs serve as proof-of-principle, the effect of
CD8+ DCs and their relationship to Aire at the level of the TCR repertoire remains
unknown.
The phenomenon of antigen transfer from mTECs to BM APCs has been
recognized for over two decades (Klein et al., 2014). It has been proposed that thymic
epithelial cells deliver antigen through exosomes, apoptotic bodies, or direct membrane
transfer (Gray et al., 2007; Humblet et al., 1994; Koble and Kyewski, 2009a; Millet et al.,
2008; Skogberg et al., 2015). The specific mechanism(s) by which this occurs in the
thymus remains unknown. CD8+ DCs, on the other hand, have been studied for their
ability to cross-present and prime CD8+ T cells in the periphery (Joffre et al., 2012).
Several non-mutually exclusive mechanisms have been reported, including uptake of
apoptotic or necrotic cells, exosome transfer, and by transfer of intact peptide/MHC
complexes (a.k.a. “cross-dressing) (Wakim and Bevan, 2011). For example, the
scavenger receptor CD36, which recognizes the apoptosis-induced expression of
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phosphatidylserine (PS), was reported to facilitate cross-presentation to MHCI-restricted
CD8 T cells by recognizing and phagocytosing apoptotic cells in one report (Albert et
al., 1998) but not others (Belz et al., 2002; Schulz et al., 2002). Whether CD36 affects
antigen transfer from mTECs for presentation to MHC II-restricted CD4 T cells is
unknown. Thus, the mechanisms by which mTEC-derived antigens are transferred to
CD8+ DCs remain unclear.
Although we proposed that CD8+ DCs are an important APC subset in thymic
tolerance, Batf3-deficient mice, which are unable to generate CD8+ DCs, have not
been reported to develop spontaneous autoimmunity. In fact, Batf3-deficient mice are
protected in the NOD model of type 1 diabetes (Ferris et al., 2014). Furthermore, Batf3deficient mice are susceptible to West Nile infection and immunogenic syngeneic
tumors (Hildner et al., 2008), suggesting an immunodeficient phenotype. An explanation
for these two opposing roles of Batf3-dependent DCs has not yet been reported. In fact,
there does not appear to be a clear indication regarding the biological importance of
mTEC to CD8+ DC antigen transfer for T cell tolerance.
By analyzing TCR repertoires in a fixed TCR model, we confirmed that Batf3dependent CD8+ DCs are required for negative and Treg cell selection, and that
approximately one-third of Aire-dependent TCRs were co-dependent on Batf3. We
found that CD36, a class B scavenger receptor preferentially expressed on CD8+, but
not SIRP+, DCs was required for the acquisition of mTEC membrane-bound I-E but
not cytoplasmic GFP, potentially via the recognition of apoptotic bodies. Finally, we
show that CD36-dependent transfer and display of cell-surface MHC on CD8+ DCs
was required for the development of direct allo-tolerance during bone marrow
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transplantation. Thus, these data suggest that CD8+ DCs utilize CD36 to acquire cellsurface antigens from mTECs to mediate thymic T cell tolerance.
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Materials and Methods

Mice
Animal breeding and experiments were performed in a specific pathogen-free animal
facility using protocols approved by the Washington University Animal Studies
Committee. All mice were on a C57BL/6 genetic background unless otherwise
indicated. TCli mice (Wong et al., 2007), Batf3–/– (Hildner et al., 2008), Cd36–/–
(Febbraio et al., 1999), Aire-G6pc2/GFP (Adig, Gardner, et al., 2008), and Gpr105–/–
(P2Y14R, Lee, et al., 2003) have all been described previously. Aire–/– (Stock# 004743),
Rag1–/– (Stock# 002216), Tcra–/–(Stock# 002116), Tcrb–/–Tcrd–/– (Stock# 002121) and
Foxp3IRES-GFP (Stock# 006772) mice were purchased from The Jackson Laboratory.
Male Balb/c mice (Stock# 028) were ordered from Charles River and allowed one week
acclimation prior to use. G25 TCR transgenic mice were generated by cloning the cDNA
for G25 TCRα chain into the VA-hCD2 expression vector, which was then co-injected
with the TCli TCRβ chain in the pTβ vector (Bautista et al., 2009). G25 transgenic mice
did not show any overt signs of autoimmunity, even on a Rag1−/− background.
Expression of TCRβ was comparable between transgenic and WT cells from the thymus
or spleen (data not shown). G25 TCR transgenic mice were bred to Foxp3IRES-GFP Rag1–
/–

mice. Animals were typically 6-10 weeks old of either sex at the time experiments

were performed.

Reagents, antibodies and flow cytometry
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Fluorescently conjugated monoclonal antibodies were purchased from Biolegend,
eBioscience, and Becton Dickenson. Y-Ae anti-I-Ab:E (52-68) peptide was obtained
from Affymetrix. Samples were analyzed using a FACSAria or FACSCanto (Becton
Dickinson) and data were processed with FlowJo (Treestar).

Thymic dendritic cell isolation and staining
Thymus was mechanically separated with scissors and digested with Liberase (125
g/ml, Roche) and DNase I (50 g/ml, New England Biolabs) in DMEM for 30 min at
37°C. Cells were stained with 2.4G2, B220, MHCII, CD11c, CD11b, CD8, SIRP,
CD24 and experiment-specific antibodies as indicated. DC subsets were identified as
follows: CD8+ DCs (CD11chi MHCIIhi B220– CD11b– SIRP– CD24+ CD8+), SIRP+
DCs (CD11chi MHCIIhi B220– CD11b+ SIRP+ CD24– CD8–), and pDCs (CD11c+
B220+).

Assessment of thymic Treg cell selection in vivo
As described previously (Bautista et al., 2009), TCR chains of interest were cloned into
the TCR-P2A-TCli retroviral vector. Foxp3IRES-GFP Rag1–/– thymocytes were
transduced with TCRs in vitro, injected intrathymically into sublethally (600 rad)
irradiated mice, and analyzed approximately 2.5 weeks later. Thymocytes were
transduced with TCR vector containing no reporter, an IRES-Thy1.1 or an IRES-huCD2
prior to injection.

Bone marrow chimeras
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BM was obtained by flushing donor humerus, tibia, and femur. BM was then RBC lysed
and T cell-depleted by labeling cells with biotinylated anti-CD4 and anti-CD8 and antibiotin microbeads, followed by magnetic cell separation using an AutoMACS (Miltenyi
Biotech). 5x106 cells were injected into either 950 rad lethally irradiated C57BL/6 host
mice or 750 rad lethally irradiated Balb/c host mice. Mice were maintained on antibiotic
water one day prior and one week after transplantation. Over 99% chimerism was
confirmed using CD45.1 WT donors.

In vitro phagocytosis assay
BM from Cd36+/– and Cd36–/– mice was cultured in 100ng/ml of Flt3L for 11 days.
CD24+ DCs were sorted, CTV labeled, and cultured with apoptotic H2 d-expressing TA3
cells for 6h. Induction of apoptosis was induced with 150mJ UV-C using a Stratalinker
UV Crosslinker. CTV+ cells were then analyzed by FACS for Y-Ae and I-Ad expression.
In some experiments, TA3 cells were pre-treated with 50uM z-VAD-FMK for 1h prior to
induction of apoptosis; or TA3 cells were cultured on the top layer of 0.4m Corning
HTS 96 well transwell plates separated from the DCs on the bottom layer. All
experiments were carried out at 37°C, as well as on ice (0°C), which allows binding but
inhibits phagocytosis.

Imaging studies
Mice were withheld food 12-24 h prior to imaging. On the day of imaging, mice were
anesthetized with 1.5-2% isoflurane in oxygen inside of a Plexiglas chamber and
subsequently injected with fludeoxyglucose (FDG, 100l/20g mouse). Mice were
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imaged using microCT to obtain anatomical scans, and then undergo a 10 min
transmission scan followed by a 10 min emission scan. All imaging was performed via a
Siemens Inveon-MM microCT/PET imager. Co-registration and analysis was performed
using Siemens Inveon Research Workplace software.

Naïve T cell transfer studies
Foxp3– CD44lo CD62Lhi G25 TCR transgenic Rag1–/– cells were sorted and retro-orbital
injected into indicated mice. In some experiments, cells were first labeled with CellTrace
violet (Thermo Fisher). For histological studies, 6-8 week old littermate male TCR–/–
mice were used. In peripheral activation studies, 6-8 week old littermate Batf3+/– and
Batf3–/– mice were used. 105 naïve T cells were injected per mouse. For peripheral
activation studies, pooled lymph nodes and spleens were harvested 4 days after
transfer.

Allogeneic bone marrow chimeras, mixed lymphocyte reaction, and acute GVHD
Initial BM chimeras were performed as described above. Eight weeks post-transplant,
thymic CD62Lhi CD24loCD4SP Tconv cells were sorted. For in vitro experiments, sorted
cells were CTV labeled and co-cultured with irradiated (2000 rad) splenocytes from
Balb/c mice. Samples were analyzed for CD25 expression and CTV dilution 5 days post
co-culture. Donor Tconv cells were distinguished from Balb/c splenocytes by H-2Kb
(AF6-88.5) and H-2Kd (SF1-1.1) expression. For in vivo experiments, 106 sorted Tconv
cells were injected into lethally-irradiated Balb/c mice concurrently receiving allogenic
5x106 T cell-depleted B6 BM. In some experiments, Tconv cells came from adult mice
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instead of from BM chimeras. Mice were assessed for weight loss beginning 4 days
post injection. Mice were sacrificed after ≥20% loss of initial body weight. Additionally,
mice were scored for disease severity using a standard 10 point scale that assesses
weight loss, posture, mobility, fur texture, and skin integrity (Cooke et al., 1996).

Data processing and statistical analysis
For TCR analysis, only TRAVs with summed reads greater than 1% in the WT multiplex
TCR data were analyzed. This accounted for more than 95% of the total TRAV
repertoire. TRAV_CDR3 species frequencies were then multiplied by a correction factor
determined by the ratio of template switch TRAV frequency to multiplex TRAV
frequency using data obtained from 2 biological replicates each with 2 technical
replicates sequenced both ways. These frequencies were used to determine the
number of a particular TRAV_CDR3 clonotype.

Graphpad Prism v6, IBM SPSS v21, and R v3.2.3 were used for used for graphical and
statistical analysis. Student’s t-tests and one-way ANOVAs with Tukey’s post hoc test
were used for between-subjects analyses unless otherwise noted. The R package
Deseq2 was used for differential TCR expression analysis; and vegan for dimensional
analysis, rarefaction, and visualization.
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Results

TCR repertoire analysis of Batf3-dependent BM derived APCs
Our previous study suggested that Batf3-dependent CD8+ DCs are the primary
subset involved in the transfer of Aire-dependent antigens from mTECs to BM APCs
(Perry et al., 2014). As this was based only on the analysis of 8 TCRs, we assessed the
impact of Batf3-deficiency globally on the TCR repertoire. Because of the great diversity
of the normal TCR repertoire, we utilized a fixed TCR model as previously described
(Perry et al., 2014), generating Batf3–/– TCR transgenic Tcra+/– Foxp3Thy1.1 mice for use
as BM donors into congenic Ly5.1 hosts. We sorted CD4SP (CD4+CD8–) Foxp3+ (Treg)
and mature CD62Lhi CD24lo CD4SP Foxp3– (Tconv) cells, whose frequencies was not
affected by Batf3-deficiency (Figure 3.1A, B). For the amplification of TRAV gene
products, we used multiplex PCR as it was more efficient than template-switch PCR in
initial experiments, permitting the analysis of smaller cell numbers (data not shown).
Barcoded amplicons were then sequenced via the Illumina MiSeq platform. To limit the
analysis to TCRs that are reproducibly detected, we excluded TRAV families that were
present at <1% of the sequences, which accounted for ~5% of the data. We also used
our previous filtering criteria (Perry et al., 2014), keeping only TCRs present at a
frequency of ≥0.01% in ≥30% of individual mice within one experimental condition (e.g.
WT Treg), leaving approximately 1600 Tconv cell TCRs in both conditions and 857 and
314 Treg cell TCRs in Batf3-sufficient and -deficient mice, respectively (Figure 3.2A).
Finally, a correction factor using template-switch PCR data as a reference standard was
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applied to limit effects of differential priming and sequencing efficiencies associated with
multiplex PCR (Figure 3.2B).
Using this processed data set, we plotted the average frequency of each TCR in
the Batf3-sufficient and -deficient conditions for both Tconv and Treg cell subsets
(Figure 3.3A). Dots in red represent individual TCRs that are markedly affected by
Batf3, based on our previous criteria (Perry et al., 2014) of p<0.05 by Mann Whitney U
(MWU) and an effect size of ≥5-fold difference in frequency (Figure 3.3A). We observed
a number of Tconv and Treg cell TCRs enriched in Batf3-deficient mice, consistent with
CD8+ DC mediated negative selection (Figure 3.3A, data points found below reference
line; 3.3B). The effect of Batf3-deficiency could also be visualized within the Tconv cell
TCR repertoire using unsupervised clustering (Figure 3.3C). In total, Batf3-dependent
DCs negatively selected ~3% and 1% of the Tconv and Treg cell TCR repertoire, which
represents ~1% and 2% of the total Tconv and Treg cell population, respectively (Figure
3.4A, B). These estimates of negative selection are likely to be conservative, as we
observed a number of TCRs that were ≥5-fold enriched but did not meet our
significance criteria (not shown) or vice versa (Figure 3.3B), suggesting that analysis of
more mice or altering the fold-change criteria could improve these estimates. As an
alternative approach, analysis of the TCR data using the DESeq2 package (Love et al.,
2014), commonly used for count data in RNA-Seq, generated comparable conclusions
(Figure 3.4B). As expected, the estimates of negative selection by Batf3-dependent
DCs are lower than historical assessments of negative selection by BM APCs using
TCR repertoire analysis (Perry et al., 2014). Thus, these data suggest that CD8+ DCs
play only a partial role in BM APC-dependent negative selection.
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By contrast to Batf3-dependent negative selection, we observed a greater
requirement for CD8+ DCs in Treg cell selection (Figure 3.3A, red dots above
reference line; 3.3B). The effect of Batf3-deficiency could also be visualized by
unsupervised clustering of Treg cell TCRs (Figure 3.3C). Notably, TCRs that we
previously identified as Batf3-dependent using retroviral expression of individual TCRs
on Rag1-deficient thymocytes (Perry et al., 2014), were also decreased in this Treg
TCR data set with Batf3-deficiency (Figure 3.5A). Although all 4 TCRs tested in vivo
showed statistical difference in the TCR repertoire data, G25 and G41 would not meet
our 5-fold effect size criteria. In addition, Batf3-deficiency results in a lower diversity in
the Treg TCR repertoire compared with the WT repertoire (Figure 3.5B), suggesting that
the selection of low frequency Treg TCRs may be compromised by deletion of CD8+
DC s. In summary, we observed that CD8+ DCs were required for selection of
approximately 20% of the unique Treg cell TCR repertoire accounting for approximately
13% of the total Treg cell TCR repertoire (Figure 3.6A, B).

Role of CD8+ DCs in Aire-dependent thymic tolerance
Aire plays an important role in T cell tolerance, in part via the induction of tissuespecific antigen production in mTECs. Aire-dependent antigens can be presented
autologously on mTECs, and may also be transferred to CD8+ DCs (Hubert et al.,
2011; Koble and Kyewski, 2009; Perry et al., 2014). Although we had previously
assessed the Aire-dependent repertoire using analysis of TRAV14 TCRs, we generated
new data using multiplex PCR to permit direct comparison with the Batf3-dataset. Within
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the range of previous results, we found that Aire was involved in the deletion of both
Tconv (~3%) and Treg (~5%) cells as well as Treg cell selection (~20%) (Figure 3.7).
We then compared the repertoires of Batf3- and Aire-dependent TCRs.
Relatively few Tconv or Treg cell TCRs were co-dependent on Batf3 and Aire for
negative selection (Figure 3.8A). By contrast, ~31% of Batf3-dependent Treg cell TCRs
were Aire-dependent and ~34% of Aire-dependent Treg cell TCRs were Batf3dependent (Figure 3.8B). These estimates are in line with our previous data suggesting
that approximately 50% of Aire-dependent TCRs are also BM APC dependent (Perry et
al., 2014). Other BM APC subsets such as SIRP+ DCs, plasmacytoid DCs,
macrophages, and B cells (Klein et al., 2014), likely contribute to negative selection,
although changes in the sequencing methodology could also affect the estimates. In
summary, the cross-comparison of Batf3 and Aire-dependent TCRs (Figure 3.9A, B)
support our previous proposal that Aire-dependent antigens are transferred to CD8+
DCs.

T cell selection by CD8+ DCs prevents tissue-specific autoimmunity
The TCR repertoire data demonstrated that Baft3-dependent CD8+ DCs are
involved in deletion and Treg cell selection. To address whether these TCRs that
escape thymic tolerance are capable of inducing autoimmunity, we transferred mature
thymic Tconv and Treg cells from Batf3- or Aire-deficient mice into T cell-deficient Tcrb–
Tcrd–/– (TCR–/–) mice and assessed tissue inflammation using Positron Emission

/–

Tomography (PET). We observed a number of tissues with increased fludeoxyglucose
(FDG) uptake in mice receiving cells from either Aire- or Batf3-deficient mice (Figure
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S3A). FDG uptake was particularly apparent in the lungs, and corresponded to obvious
inflammation on histology (Figure 3.10A, B). In addition to analysis of polyclonal T cells,
we asked whether pathology could be induced by naïve T cells expressing the Treg
TCR G25, which we had previously observed to be Batf3/Aire-codependent for Treg cell
selection in vivo via retroviral TCR expression in thymocytes (Perry et al., 2014).
Transfer of Tconv cells from G25 transgenic Foxp3IRES-GFP Rag1–/– mice into TCR–/–
mice resulted in significant weight loss and lung inflammation (Figure 3.11A)
reminiscent of polyclonal T cell transfers from Batf3- or Aire-deficient mice. Thus, these
data support the notion that Batf3, like Aire, limits autoimmunity via induction of thymic T
cell tolerance.
However, Batf3-deficient mice have not been reported to develop overt
autoimmunity (Hildner et al., 2008). We hypothesized that this might result from a defect
in peripheral antigen presentation. Consistent with this hypothesis, it was reported that
Batf3-deficiency abrogates the development of Type 1 Diabetes in the NOD model
(Ferris et al., 2014). To further test this possibility, we asked whether peripheral CD8+
DCs were required to activate cells expressing the thymic Batf3-dependent Treg TCR
G25 in vivo. Naïve G25 TCR transgenic cells were labelled with cell trace violet (CTV)
and injected into Batf3-sufficient or -deficient hosts. We observed that the proliferation
of G25 TCR transgenic cells was diminished in Batf3-deficient mice (Figure 3.11B). We
also tested peripheral activation of 7 additional TCRs that were Batf3-dependent or independent for thymic Treg cell induction (Perry et al., 2014), via retroviral transduction
of these TCRs into TCli TCR transgenic Rag1–/– CD4+ cells (Hsieh et al., 2006).
Notably, TCRs that exhibited Batf3-dependence in the thymus also showed decreased
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expression of TCR activation markers after transfer into Batf3-deficient compared with
Batf3-sufficient hosts (Figure 3.11C). Thus, analysis of these 8 TCRs support the
hypothesis that CD8+ DCs are involved in presenting a distinct array of antigens in
both the thymus as well as the periphery.

CD36 is involved in transfer of cell-surface antigens from mTECs
We next sought to determine the mechanism(s) by which CD8+ DCs acquire
antigens from mTECs. One possibility was that CD8+ DCs, via their expression of the
chemokine receptor XCR1 (Bachem et al., 2012; Lei et al., 2011), are in closer physical
proximity to mTECs than other BM APC subsets. Another non-mutually exclusive
hypothesis is that CD8+ DCs uniquely express receptors that facilitate antigen transfer
from mTECs. Query of the Immunological Genome Project (ImmGen) (Heng et al.,
2008) database revealed one potential candidate, CD36, which was expressed at a
much higher level on thymic and splenic CD8+ DCs compared with other DC subsets.
Notably, CD36 has previously been reported to recognize PS (Rigotti et al., 1995) and
facilitate the acquisition and presentation of antigens derived from apoptotic cells (Albert
et al., 1998). In addition, apoptosis has been reported as part of the normal mTEC life
cycle (Gray et al., 2007). Thus, the published expression and function of CD36
suggested it might play a role in mTEC antigen transfer to CD8+ DCs.
To address this possibility, we first confirmed that CD36 is uniquely expressed on
the CD8+ subset of thymic DCs (Figure 3.12). We then tested whether CD36 was
involved in the transfer of cell-surface antigens using BM chimeras into Balb/c hosts that
express the MHC II molecule E. As B6 mice do not express E, the generation of E:I71

Ab complexes, as detected using the peptide-in-groove antibody Y-Ae, occurs via
antigen transfer from mTECs (Humblet et al., 1994). Consistent with our previous
report (Perry et al., 2014), we observed preferential presentation of E:I-Ab by donorderived CD8+ versus SIRP+ DCs (Figure 3.13). Notably, this was markedly
diminished in CD8+ DCs from Cd36–/– bone marrow (Figure 3.13), which was not a
result of lower MHCII levels (data not shown). Thus, CD36 plays an important role in
mediating the transfer of cell-surface antigens from mTECs to CD8+ DCs.
We also asked whether CD36 was involved in mediating antigen transfer of
cytoplasmic antigen from mTECs. Previously, we had utilized BM chimeras to assess
whether GFP expressed in host cells via an Actin-GFP transgene could be transferred
to transgene-negative donor BM APCs (Perry et al., 2014). Because Actin-GFP is
expressed on all radioresistant host cells, and not just mTECs, we instead used the
Adig BAC transgene, where GFP is expressed only in mTECs via the Aire promoter
(Gardner et al., 2008). Analysis of Cd36+/+ bone marrow donor APC subsets into Adig +
hosts confirmed our previous conclusion that CD8+ DCs preferentially acquired GFP
from host mTECs, with little uptake in SIRP+ DCs (Figure 3.14). In contrast to its effect
on E transfer, CD36 expression did not affect cytoplasmic GFP acquired by CD8+
DCs. Thus, the requirement of CD36 for cell-surface, but not cytoplasmic, model
antigens, demonstrates the existence of multiple pathways of antigen transfer from
mTECs to CD8+ DCs.
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Effect of CD36 on the Tconv and Treg cell TCR repertoire
Though the effect of CD36-deficiency on the transfer of E was substantial, it
remained possible that this was a unique interaction between CD36 and E and not a
general effect of CD36-deficiency on CD8+ DC antigen presentation. We therefore
asked whether CD36-deficiency affected the thymic TCR repertoire. We bred Cd36–/–
TCli transgenic mice and used them as BM donors into congenic hosts, and
sequenced the Treg and mature Tconv cell subsets (Figure 3.15). As with Baft3deficiency (Figure 3.1A, B), we did not observe effects of CD36 deficiency on the
CD4SP, Tconv, or Treg cell frequencies (data not shown). Similarly, we found that most
TCRs were unaffected by CD36 deficiency (Figure 3.16A, points on the diagonal).
However, the TCR repertoire analysis revealed a requirement for CD36 for negative
selection of a subset (~2%) of the Tconv cell TCR repertoire and the selection of ~7% of
the Treg cell TCR repertoire (Figure 3.16B, C). The effects of CD36 on the TCR
repertoire could also be delineated by PCA analysis (Figure 3.16D). In addition, we
corroborated our sequencing data with in vivo development studies of CD36-dependent
(R35, R117) and -independent (G25, G41) Treg cell TCRs (Figure 3.17A-C). Of note, all
of these TCRs were previously reported to be Batf3- and Aire-codependent for selection
of Treg cells in vivo (Perry et al., 2014). We also tested 4 Batf3/Aire-independent Treg
cell TCRs in vivo and found that they were not affected by CD36 deficiency as expected
(Figure 3.18). Taken together, these data demonstrate that CD36 has a clear effect on
the Treg and Tconv cell TCR repertoire.
By cross-referencing our data sets from CD36 and Batf3-deficient conditions, we
observed that the majority of Batf3-dependent TCRs were not affected by CD36,
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suggesting that CD36 does not globally affect CD8+ DC antigen presentation. Since
CD36 is expressed on macrophages in addition to CD8+ DCs, we also asked if there
were TCRs affected by CD36 that were not dependent on Batf3. However, all of our
CD36-dependent TCRs were Batf3-dependent (Figure 3.19), suggesting that the effect
of CD36 on the TCR repertoire is due to its expression on CD8+ DCs.
We then asked whether CD36 was important for antigen transfer, which we infer
based on TCRs that are codependent on Aire and Batf3. Of the few Tconv cell TCRs
codependent on Batf3 and Aire for negative selection, 50% were also dependent on
CD36 (Figure 3.19). Similarly, approximately half of the Treg cell TCRs codependent on
Batf3 and Aire also required CD36 for Treg cell selection (Figure 3.19). Thus, these
data suggest that CD36 contributes substantially to cooperative antigen presentation of
Aire-dependent antigens by Batf3-dependent CD8+ DCs for the development of T cell
tolerance.

CD36 acquires cell-surface antigen via scavenging of apoptotic bodies
We next sought to determine the process by which CD36 facilitated antigen
acquisition from mTECs in vitro. As we are not aware of an Aire + H-2d-expressing mTEC
line, we used the TA3 hybridoma line as an imperfect surrogate (Glimcher et al., 1983).
CD36-sufficient and -deficient BM-derived CD24+ DCs, which are of a similar
developmental lineage as thymic CD8+ DCs (Naik et al., 2005), were co-cultured with
apoptotic TA3 cells for 6 hours and then stained for Y-Ae binding. Consistent with our in
vivo data (Figure 3.13), we observed that the transfer and presentation of TA3-derived
E on I-Ab in DCs was CD36-dependent (Figure 3.20A).
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MHC molecules can be acquired through endocytosis, in which transferred E
would be degraded and presented via the typical MHC II peptide-loading pathway. A
non-mutually exclusive possibility is that intact MHC molecules are transferred via
trogocytosis, such that the initial site of uptake would be the DC cell-surface membrane,
followed by MHC internalization and degradation. Consistent with the latter, we
observed diminished I-Ad expression on CD36-deficient CD24+ DCs after co-culture with
apoptotic TA3 cells (Figure 3.20B). We also asked whether I-Ad could be picked up in
this manner by CD8+ DCs in vivo. However, it appeared that the process of enzymatic
digestion at 37°C for DC isolation in itself might result in cell-surface MHC transfer,
rendering the in vivo analysis uninterpretable (Figure 3.21). The 30 minute digestion
appears to be insufficient to result in E:I-Ab complexes detectable by Y-Ae (Figure
3.21). While accurate in vivo data is unavailable, our in vitro data suggests that CD36
may be involved in the “cross-dressing” of intact cell surface MHC molecules to be
displayed on CD8+ DCs.
CD36 has several known ligands, including PS and thrombospondin on apoptotic
bodies or exosomes that could be involved in antigen transfer from mTECs. To assess
the role of apoptotic bodies in E acquisition and presentation in vitro, we pre-treated
TA3 cells with the pan-caspase inhibitor z-VAD-FMK prior to co-culture with CD24+
DCs. Inhibition of apoptosis resulted in significantly diminished acquisition and
presentation of E, which was further decreased in conjunction with CD36-deficiency
(Figure 3.22). To assess the role of exosomes, we cultured cells separated by a 0.4m
membrane sufficient to allow their passage. This reduced the acquisition and
presentation of E, arguing against a role for exosomes (Figure 3.22). However, it
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remains possible that the concentration of exosomes generated was insufficient to
overcome the different physical characteristics of the culture system. While these data
cannot exclude a role for exosomes, our in vitro data support the published notion that
CD36 is involved in the recognition of apoptotic bodies.
Along with “eat me” signals, the phagocytosis of apoptotic cells also requires a
signal to home to a dying cell (a.k.a. “find me”), including purine nucleosides and
nucleotides, such as ATP (Poon et al., 2014). We asked whether there were purinergic
receptors that were differentially expressed by thymic CD8+ DCs. Analysis of ImmGen
revealed that Gpr105 (a.k.a. P2Y14R), an UDP-glucose-responsive metabotropic
receptor (Abbracchio et al., 2003; Lee et al., 2003), is highly expressed by both thymic
and splenic CD8+ DCs but not SIRP+ DCs. Transfer of Gpr105-deficient BM into
Balb/c mice resulted in a significant decrease in E presentation by CD8+, but not
SIRP+, DCs (Figure 3.23). Taken together, our in vitro and in vivo data support the
notion that CD8+ DCs use CD36 to acquire cell-surface antigens from apoptotic
mTECs.

CD36-dependent antigen transfer is necessary for direct allo-tolerance development
Based on previous reports (Dolan et al., 2006; Li et al., 2012; Qu et al., 2009;
Wakim and Bevan, 2011), as well as our in vitro observation that MHC II can be
transferred directly to the cell surface of CD8+ DCs, we asked whether this might be
involved in the development of thymic tolerance in vivo during allo-mismatched bone
marrow transplantation. In a fully mismatched allogeneic BM chimera, donor thymocytes
are positively selected by host MHC on cTECs, and negatively selected by donor MHC
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on BM APCs as well as host MHC on cTECs and mTECs. Antigen transfer of MHC
molecules from mTECs to DCs would therefore be predicted to facilitate thymic
tolerance to host MHC.
To test this, we generated fully-MHC mismatched allogeneic BM chimeras using
C57BL/6 (B6) donors and Balb/c hosts. Mature Tconv thymocytes from these mice were
then assessed for their ability to induce acute graft-versus-host disease (GVHD) in the
context of BM transplantation (Figure 3.24). As expected, thymic Tconv cells from
Batf3+/– B6  Balb/c BM chimeras showed minimal evidence of acute GVHD compared
with Tconv cells from B6  B6 autologous BM chimeras that were not exposed to H-2d
in the thymus (Figure 3.25A). The process of BM chimera generation did not appear to
affect acute GVHD, as Tconv cells from normal B6 mice were equivalent to syngeneic
B6 BM chimeras in their ability to induce acute GVHD (Figure 3.25B). Thus, these data
confirm that thymic T cell tolerance to host MHC occurs during allogeneic BM
transplantation.
By contrast, loss of thymic tolerance occurred with deficiency in either Batf3 or
CD36 in the donor B6 background BM. Tconv cells from the respective BM chimeras
induced acute GVHD as assessed by weight loss, clinical score, and time to euthanasia
(Figure 3.25A). Tconv cells from Cd36–/–  Balb/c chimeras were marginally less potent
than Batf3–/–  Balb/c chimeras, consistent with the incomplete block of MHC transfer
with CD36 deficiency (Figure 3.13). We did not find evidence for a cell-intrinsic T cell
hyper-reactivity imparted by Batf3-deficiency, as T cells from non-chimeric Batf3deficient and -sufficient mice showed similar induction of GVHD (Figure 3.25C). Thus,
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these data suggest that CD36-dependent MHC transfer to CD8+ DCs is required for
thymic allo-tolerance.
Allo-recognition can occur via direct recognition of allogeneic MHC by the TCR,
or indirectly via recognition of allogeneic peptides presented on self-MHC (e.g.. E
peptide on I-Ab). To test direct allo-recognition, we sorted Tconv cells and cultured them
in the presence of irradiated Balb/c splenocytes (Figure 3.24). Tconv cells from Batf3+/–
 Balb/c chimeras showed minimal proliferation, consistent with the in vivo results
suggesting that these cells are allo-tolerant (Figure 3.26). However, we observed a
clear population of proliferated Tconv cells from Batf3–/–  Balb/c or Cd36–/–  Balb/c
chimeras (Figure 3.26), consistent with direct allo-recognition. However, the frequency
of proliferated cells was lower than Tconv cells from non-tolerant conditions using
autologous B6 hosts (Figure 3.26), suggesting that a partial degree of allo-tolerance
does occur to host MHC presented on cTECs and mTECs. A deficiency in tolerance to
direct allo-recognition is also consistent with the early time course of GVHD in vivo
(Figure 3.25A), as donor APCs would not have seeded the periphery in large numbers.
In summary, these data suggest that complete tolerance to direct host MHC recognition
during allogeneic BM transplantation requires CD36-dependent “cross-dressing” of
CD8+ DCs.
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Figure Legends
Figure 3.1. Thymocyte subset frequencies in TCli + Batf3–/– mice.
(A,B) No change in thymic T cell population due to Batf3-deficiency. Summary of Foxp3+
CD4+ (Treg), Foxp3– CD4+ CD8– (CD4SP) and CD8+ CD4– (CD8SP) thymocyte frequencies (A)
or HSAlo CD62hi and HSAhi CD62lo CD4+ frequencies (B) from TCli transgenic Batf3+/+ or Batf3–
/–

 Ly5.1 BM chimeras. Data are presented as mean + SEM.

Figure 3.2. TCR sequencing output for Batf3+/+ and Batf3–/– mice.
(A) Illumina sequencing of Tconv and Treg cell TCRs from Batf3+/+ and Batf3–/–
BM chimeras. Chimeras were generated using TCli TCR transgenic Tcra+/– (Batf3+/+ or
Batf3–/–) donors. After 8 weeks, Foxp3+ Treg (CD4+CD8–Foxp3gfp+) and Foxp3– Tconv
(CD4+CD8–CD62LhiCD24loFoxp3gfp–) cells were sorted. Synthesis of TCR cDNAs from
purified T cells was performed using the C-specific primer 5’GTGAATCAGGGCCAAC-3’. A two-step PCR was used in order to amplify multiple
TRAV genes (multiplex PCR, see Table S1). Amplicons were purified after each PCR
reaction using the Agencourt AMPure XP magnetic purification system. The ~200-600 bp
amplicons were quantified using Qubit dsDNA BR assay kit (Invitrogen) and pooled in equimolar
ratios for 250 bp paired end sequencing via the MiSeq platform (Illumina). Sequences were

demultiplexed and analyzed using blastn to identify the TRAV and TRAJ gene
segments using the IMGT database (Giudicelli et al., 2006). This information was then
used to determine the CDR3 sequence. A unique TCR is identified by its TRAV and
CDR3 amino acid sequence. Data shown is the summary of sorting, sequencing, and
filtering. Frequency filtering (“# of TCRs > .01%”) keeps TCRs > 0.01% of raw data in
any individual sample. Consistency filtering (“# TCRs > 30% of condition”) keeps TCRs
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that are found in 30% of samples at > 0.01% frequency within an experimental condition
defined by T cell subset and genotype. Raw sequence data can be found in the
European Nucleotide Archive (accession # ). (B) Primer efficiency of multiplex PCR.
Template switch (Mamedov et al., 2013) or conventional cDNA synthesis was
performed on thymic Tconv cells and sequenced (2 biologic and 2 technical replicates).
The frequency of each TRAV is shown. TRAVs with a frequency below 1% of the total
population in multiplex PCR were excluded to limit variability from low read numbers
due to low primer efficiency. The TRAV frequency in template switch divided by the
frequency in multiplex PCR was used as a correction factor.

Figure 3.3. Treg and Tconv cell TCR sequencing of Batf3+/+ and Batf3–/– mice.
(A) Batf3-dependent CD8+ DCs are required for T cell tolerance. The average TCR
frequency in the Tconv (Foxp3– HSAlo CD62hi) and Treg (Foxp3+) cell subset in Batf3+/+ or Batf3–
/–

 Ly5.1 BM chimeras are shown. Red dots indicate TCRs that show p < .05 MWU and 5-fold

change between Batf3–/– and Batf3+/+. (B) Plots of raw TCR frequencies for the top 10 Treg
TCRs in Batf3+/+ and Batf3–/– BM chimeras (left) and the top 10 negative or Treg selected TCRs
sorted by MWU p value (right). Dots indicate data from individual mice and bars indicate the
mean. *p < .05, **p < .01, ***p < .001, MWU. (C) Unsupervised clustering analysis of Tconv and
Treg cell TCR repertoires from Batf3 BM chimeras.

Figure 3.4. CD8+ DCs mediate negative selection of Tconv and Treg cells.
(A) Summary of the effect of Batf3 on negative selection and Treg cell selection. Data
shown are the percentage of unique TCRs or total sequences affected based on criteria
described in (Figure 3.2). All data are representative of at least two independent experiments
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with at least 4 mice per condition. (B) Analysis of negative selection using the R package

DESeq2. Presented is the unique number of TCRs determined by the false-discovery
rate adjusted p value (padj), the unadjusted p value (pval), with or without a 5-fold
change criteria (5x).

Figure 3.5. Cross-validation of Batf3–/– sequencing data set.
(A) Frequency in Batf3+/+ and Batf3–/– TCR data sets of Treg cell TCRs previously
identified to be Batf3- and Aire-codependent (G25, G41, R117, R35) or -independent
(G69, R19, JP2, JP3) in in vivo developmental studies (Perry et al., 2014). (B)
Rarefaction of Treg cell TCR repertoires from Batf3+/+ (WT) and Batf3–/– (KO) BM
chimeras using the R package “vegan” (Oksanen et al., 2016). *p < .05, **p < .01, ***p <
.001, Student’s t-test.

Figure 3.6. CD8+ DCs mediate Treg cell development.
(A) Summary of the effect of Batf3 on Treg cell selection. Data shown are the
percentage of unique TCRs or total sequences affected based on criteria described in (Figure
3.2). All data are representative of at least two independent experiments with at least 4 mice per
condition. (B) Analysis of Treg cell selection using the R package DESeq2. Presented is

the unique number of TCRs determined by the false-discovery rate adjusted p value
(padj), the unadjusted p value (pval), with or without a 5-fold change criteria (5x).

Figure 3.7. Multiplex TCR sequencing of Aire–/– mice.
(A) Summary of TCR sequencing to assess role of Aire. Foxp3– Tconv or Foxp3+
Treg CD4SP cells from TCli+ transgenic  Aire+/+ or Aire–/– BM chimeras were
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sequenced as per Figure 3.2. (B) Average TCR frequencies in the Foxp3 – and Foxp3+
Aire data sets. Red dots indicate TCRs that are considered Aire-dependent based on p
< .05 (MWU) and 5-fold change as per Figure 3.3. (C) PCA of Tconv and Treg cell TCR
repertoires from Aire+/+ (blue dots) and Aire–/– (red dots) BM chimeras. (D,E) Summary
of the effect of Aire on negative selection of the Foxp3– and Foxp3+ TCR repertoire (D),
and on Treg cell selection (E). Data shown are the percentage of unique TCRs or total
sequences affected. (F) Rarefaction of Treg cell TCR repertoires from Aire+/+ (WT) and
Aire–/– (KO) BM chimeras as per Figure 3.5

Figure 3.8. Analysis of Batf3/Aire-codependence for deletion and Treg cell
selection.
(A,B) Intersection between Aire and Batf3-dependent TCRs. Venn diagram of absolute
number of TCRs involved in negative selection (A) or Treg cell selection (B).

Figure 3.9. Quantification of cell-autonomous and cooperative antigen
presentation by CD8+ DCs for deletion and Treg cell selection.
(A,B) Summary of the effect of Batf3 and Aire on negative selection (A) and Treg cell
selection (B). TCRs are identified as Batf3/Aire dependent based on Figure 3.3.

Figure 3.10. T cell selection by CD8+ DCs prevents tissue-specific autoimmunity.
(A) Representative images from FDG PET imaging (top row) and hematoxylin and eosin
(H&E) stained lung histology (bottom row) of TCR–/– mice injected with sorted thymic Tconv
(106) and Treg (5x104) cells from wild-type (WT), Aire–/–, or Batf3–/– mice. Mice were imaged 2.5
weeks post transfer. Yellow arrows indicate regions of increased radiolabeled glucose uptake.
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Images are representative of two independent experiments with 2-3 mice per condition. (B)
Quantification of radiolabeled glucose uptake in lung, spleen, and muscle from (A). Data is
represented as change from WT (counts KO ÷ WT). Each dot represents data from an individual
mouse; bar indicates mean value. *p < .05, **p < .01, ***p < .001; Student’s t-test.

Figure 3.11. Peripheral Batf3-dependent DCs are required for activation of thymic
CD8+ DC-dependent TCRs.
(A) Pathogenic potential of G25 TCR. TCR–/– mice were injected with 106 G25 TCR
transgenic or polyclonal thymic Tconv cells. Weights (mean ± SEM) were measured weekly,
and analyzed using repeated measures ANOVA with Sidak’s multiple comparisons correction.
Lungs were harvested for H&E staining. (B) Decreased peripheral activation of G25 TCR. 105
Naïve G25 TCR transgenic CD4+ T cells were sorted, cell trace violet (CTV) labeled, and
injected into Batf3+/– or Batf3–/– mice. Proliferation of and CD44 expression by G25 cells was
assessed by flow cytometry of the spleens and pooled lymph nodes (LN) 4 days after transfer.
Each dot represents data from an individual recipient from two independent experiments. (C)

Peripheral T cell activation of Batf3-dependent TCRs. CD4+ T cells from TCli TCR
transgenic mice were enriched and CD25-depleted using Automacs, then stimulated for
24h with plate bound CD3/CD28 antibody. T cells were retrovirally transduced (Hsieh et
al., 2006) with the indicated TCR chains and injected into 6-8 week old littermatecontrolled Batf3+/– and Batf3–/– mice. Spleens and pooled lymph nodes were harvested
11 days post injection and stained for CD44 as a surrogate for T cell activation. Data is
presented for each replicate, and was obtained in at least two independent experiments.
*p < .05, **p < .01, ***p < .001; Student’s t-test.
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Figure 3.12. CD36 expression is restricted to CD8+ DCs in the thymus.
WT thymi were harvested and stained for DC markers and CD36 as described in
Methods. Plots are representative of two separate experiments with at least 2 mice per
condition.

Figure 3.13. CD36 is involved in transfer of cell-surface antigens from mTECs.
BM from Cd36+/– and Cd36–/– mice was transferred into irradiated H-2d hosts.
CD8+ and SIRP+ DC subsets were analyzed for Y-Ae expression 4 weeks after
transplantation. Gates were drawn according to H-2b syngeneic BM chimera controls.
Plots summarize data from two experiments with 2 mice per condition (mean + SEM).
***p < .001; Student’s t-test.

Figure 3.14. CD8+ DCs mediate transfer of cytoplasmic antigen independent of
CD36.
BM from Cd36+/+ Ly5.1+ and Cd36–/– mice was transplanted at a 1:1 ratio into
mice expressing a BAC transgene in which Aire drives GFP expression (Adig). CD8+
and SIRP+ DC subsets were analyzed for GFP expression 4 weeks after
transplantation, using gates from BM chimeras using Adig-negative hosts. Plots
summarize data from one experiment with four Adig + mice (mean + SEM). ***p < .001;
Student’s t-test.

Figure 3.15. TCR sequencing output for Cd36+/– and Cd36–/– mice.
Summary of TCR sequencing for CD36 BM chimeras as described in Figure 3.2.
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Figure 3.16. Treg and Tconv cell TCR sequencing of Cd36+/– and Cd36–/– mice.
(A) Effect of CD36 on the TCR repertoire. Plotted are the average frequency of
Tconv and Treg TCRs in Cd36+/– or CD36–/–  Ly5.1 BM chimeras. Red dots indicate
TCRs that show p < .05 MWU and 5-fold change. (B, C) Summary of CD36 on negative
selection (B) and Treg cell selection (C). Data shown are the percentage of unique
TCRs or total sequences in the filtered data set that are negatively selected based on
MWU and fold-change criteria in (A). (D) Unsupervised clustering analysis of Tconv and
Treg cell TCR repertoires from Cd36+/– and Cd36–/– BM chimeras.

Figure 3.17. In vivo validation of the behavior of Batf3/Aire-codependent Treg cell
TCRs observed in Cd36+/– and Cd36–/– TCR sequencing.
(A) Frequency of Treg cell TCRs in Cd36+/– and Cd36–/– BM chimeras previously
identified to be Batf3/Aire-codependent (G25, G41, R117, R35) in in vivo developmental
studies (Perry et al., 2014). (B) In vivo developmental studies of Batf3/Aire-dependent
Treg cell TCRs: two CD36-independent (G25 and G41) and two CD36-independent
(R35 and R117). Representative flow cytometry plots (gated on retrovirally transduced
CD4SP cells) of data summarized in (C). Plots are representative of at least two
independent experiments with 1-3 replicates per condition. ***p < .001, Student’s t-test.

Figure 3.18. In vivo validation of the behavior of Batf3/Aire-independent Treg cell
TCRs observed in Cd36+/– and Cd36–/– TCR sequencing.
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In vivo developmental studies of previously identified CD11c + DC-dependent
Batf3/Aire-independent Treg TCRs (Perry et al., 2014). Each TCR was tested in at least
two independent experiments with at least 1 replicate per condition. Summary data and
representative FACS plots are shown.

Figure 3.19. Analysis of CD36/Batf3/Aire-codependence for deletion and Treg cell
selection.
Cross-referencing of CD36/Batf3/Aire-dependent TCRs. Venn diagram
representations of Tconv and Treg cell TCRs dependent on Batf3, Aire, and CD36.
Values represent absolute number of TCRs, and Venn diagram sections are sized
proportional to number. All sequencing data are representative of two independent
experiments with 5 mice per condition.

Figure 3.20. CD36 mediates acquisition and presentation of intact peptide/MHC in
vitro.
(A) In vitro assessment of CD36 function in antigen presentation. Cd36+/– and
Cd36–/– BM-derived CD24+ DCs were co-cultured with apoptotic H-2d-bearing TA3 cells
for 6h at 0”C and 37”C. Acquisition and presentation of E by CD24+ DCs was
quantified using the Y-Ae antibody. FACS plots are representative of three independent
experiments with at least two independent replicates per condition. Transfer of cellsurface I-Ad in vitro to BM DCs. As per (A), Cd36+/– and Cd36–/– BM-derived CD24+ DCs
were co-cultured with apoptotic H-2d-bearing TA3 cells for 6h at 0°C and 37°C.
Acquisition of intact peptide/MHC from TA3 cells was determined by flow cytometry of I-
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Ad expression on CD24+ DCs. FACS plots are representative of two independent
experiments with at least two independent replicates per condition. All data are
summarized as mean + SEM. **p < .01, ***p < .001, one-way ANOVA with Tukey’s post
hoc test.

Figure 3.21. Measurement of in vivo transferred intact peptide/MHC is obscured
by thymic digestion.
Thymic digestion can transfer cell surface MHC. Shown is experiment schematic
and representative FACS plots. Thymi from congenic Ly5.1+ B6 (C57BL/6) and Balb/c
mice were harvested, split in half, and either digested by itself or with an allogeneic
thymus. Thymus preps were stained for DC markers, Y-Ae, and I-Ad, and analyzed by
flow cytometry. FACS plots are representative of two independent experiments with two
replicates per condition. DC subsets were identified as per Methods.

Figure 3.22. CD36 acquires cell-surface antigen via scavenging of apoptotic
bodies.
Blockade of apoptosis and apoptotic bodies decreases E presentation. TA3
cells were pre-treated with 50M z-VAD-FMK (zVAD) 1h prior to co-culture as in (Figure
3.20). For transwell experiments, CD24+ DCs were cultured in the bottom chamber and
apoptotic TA3 cells in the top chamber of a 0.4m transwell plate. FACS plots are
representative of two independent experiments with at least two independent replicates
per condition. All data are summarized as mean + SEM. ***p < .001, one-way ANOVA
with Tukey’s post hoc test.
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Figure 3.23. The purinergic receptor GPR105 (P2Y14R) mediates transfer of cellsurface antigen from mTECs.
Gpr105 is required for antigen-transfer of E. Gpr105+/+ Ly5.1+ and Gpr105–/– BM
was injected into lethally irradiated Balb/c mice at a 1:1 ratio. Thymi were harvested 4
weeks post injection, as per Figure 4, and CD8+ and SIRP+ DC subsets were
analyzed for Y-Ae expression. Data are representative of two experiments with 3-4 mice
per condition. All data are summarized as mean + SEM. ***p < .001, one-way ANOVA
with Tukey’s post hoc test.

Figure 3.24. Experimental design to assess tolerance during allogeneic bone
marrow transplantation.
Schematic for the assessment of tolerance during allogeneic bone marrow
transplantation performed in Figures 3.25 and 3.26. T cell-depleted BM was harvested
from indicated mice and transplanted into either allogeneic Balb/c or syngeneic
C57BL/6 (B6). After 8 weeks, CD4+ thymic Tconv cells were sorted and used for either
induction of acute GVHD (Figure 3.25) or to detect alloreactivity in a mixed lymphocyte
reaction (Figure 3.26).

Figure 3.25. Batf3/CD36-dependent antigen transfer facilitates allo-tolerance
development and prevents catastrophic acute GVHD.
. (A) Acute GVHD model: BM from H-2b Batf3+/–, Batf3–/–, or Cd36–/– mice was

transplanted into Balb/c H-2d hosts. As a positive control, Batf3+/– H-2b BM was
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transplanted into Ly5.1+ H-2b hosts. After 8 weeks, thymic CD4+ Tconv cells were sorted
and 106 cells were co-injected with T cell-depleted H-2b BM into H-2d hosts. (B) Similar
to experiment described in (A), except that thymic CD4 + Tconv cells were sorted directly
from B6 mice versus syngeneic B6  B6 BM chimeras. (C) Similar to (B), except Tconv
cells from Batf3+/– and Batf3–/– mice were used to induce acute GVHD. The course of
acute GVHD was determined by weight change, clinical score, and the fraction of mice
reaching 20% weight loss requiring euthanasia. Summary plots are of 2-4 independent
experiments with 2-4 mice per condition (mean ± SEM).

Figure 3.26. CD36-dependent antigen transfer is necessary for direct allotolerance in the thymus.
In vitro direct MLR: 2.5x104 Tconv cells obtained as per (Figure 3.25) were CTV
labeled and cultured with irradiated H-2d splenocytes (2.5x104 cells) for 5 days.
Proliferation of Tconv cells was assessed by CTV dilution using flow cytometry. Plots
are representative of 2-3 independent experiments. Each dot in the summary plot
represents the average of 2 technical replicates from an individual mouse; bar indicates
group mean. ***p < .001, one-way ANOVA with Tukey’s post hoc test.
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Discussion
Although the process of antigen transfer of self-proteins from mTECs to BM
APCs has been recognized for over 2 decades, a mechanism for this process has not
been described. We make the following observations regarding cooperative antigen
presentation of mTEC-derived antigens. First, Batf3-dependent CD8+ DCs play an
important role in Aire-dependent thymic tolerance based on TCR repertoire analysis in a
fixed TCR model. Second, antigen transfer from Aire-expressing mTECs to CD8+
DCs occurs via at least two distinct routes that segregate between cell-surface and
cytoplasmic antigens. Third, cell-surface antigen transfer is mediated by CD36, a
scavenger receptor preferentially expressed on the CD8+ subset of DCs. Finally, an
intermediate step in CD36-mediated antigen transfer involves the display of cell-surface
proteins, a.k.a. cross-dressing, which appears necessary for the generation of tolerance
to host MHC during allo-bone marrow transplantation. Thus, our data demonstrate that
antigen transfer can occur via multiple pathways, and suggest that CD36-mediated
uptake of cell-surface proteins by CD8+ DCs plays an important role in tolerance to
mTEC-derived antigens.
Previous studies have suggested that thymic CD8+ DCs are important in thymic
tolerance. For example, CD8+ DCs have been reported to home to mTECs via the
mTEC-derived chemokine XCL1 (Lei et al., 2011). Moreover, we recently showed using
a panel of 8 TCRs that Batf3-dependent CD8+ DCs were associated with antigen
transfer (Perry et al., 2014). Here, we have quantified the effect of Batf3-deficiency on
the CD4SP TCR repertoire in a fixed TCR model. The analysis of a fully polyclonal
repertoire introduces the experimental complexity of pairing  and  chains for
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sequencing, as well as increased mouse to mouse variability due to the much greater
repertoire diversity. With this restriction in mind, our results demonstrate that Batf3dependent DCs affect both negative selection and Treg cell selection. Cross-correlation
with effect of Aire on the TCR repertoire led to an estimate that CD8+ DCs contributes
to only ~6-9% of Aire-dependent negative selection, versus ~ 34% for Aire-dependent
Treg cell selection. This is reminiscent of our previous results with C2TAkd of MHCII on
mTECs, which affected ~ 30% of Treg TCRs, but only 5% of negatively selected TCRs.
We speculate that this may arise from differences in co-stimulatory molecules between
APC subsets, or in the level of antigen presentation achieved after antigen transfer
versus autologous presentation. While future experiments are required to test these
hypotheses, our TCR repertoire analysis supports the notion that CD8+ DCs have
substantial interactions with mTECs for cooperative antigen presentation and Treg cell
selection.
The TCR repertoire data from Batf3-deficient mice suggests that there should be
a loss of tolerance to certain Aire-dependent antigens. We confirmed that these defects
in thymic selection result in enhanced immunopathology after transfer of thymocytes
into lymphopenic hosts. These findings are similar to those observed in recipients of
Tconv cells transferred from Aire-deficient mice, as well as in recipients of Tconv cells
from Batf3/Aire-co-dependent Treg cell TCR (G25) transgenic mice. These data
therefore support the TCR analysis suggesting that CD8+ DCs are involved in Airemediated tolerance.
However, overt autoimmunity has not been reported in Batf3-deficient mice. One
possibility is that, similar to Aire-deficient mice on the C57BL/6 background (Hubert et
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al., 2009), peripheral mechanisms restrain autoimmunity. Alternatively, we and others
hypothesized that CD8+ DCs might be involved in both thymic tolerance as well as
presentation of those antigens in the periphery (Klein et al., 2014; Perry et al., 2014).
This hypothesis was supported by our observation that 4 Batf3-dependent TCRs
showed diminished peripheral T cell activation in Batf3-deficient hosts. This is also
consistent with recent work demonstrating that intrathymic injection of peripheral DCs
from skin-draining LNs increased thymic Treg cell development of an Aire/BM APCdependent Treg cell TCR (Lin et al., 2016). In addition, Batf3-deficiency on the NOD
background protects mice from autoimmune diabetes (Ferris et al., 2014), suggesting
an important role for this DC subset in peripheral autoantigen presentation. Taken
together, our data imply that CD8+ DCs contribute to both thymic deletion and Treg cell
selection of a subset of self-reactive TCRs, but may also be involved in antigen
presentation to those same TCRs in the periphery.
The theory that CD8+ DCs might perform the same antigen presentation
function in the thymus as well as the periphery raises the question whether antigen
transfer in the thymus is a unique process. It may be beneficial for the immune system
to use the same APCs in the thymus that present particular self-antigens in the
periphery. First, it is well established that the antigen processing machinery in DCs is
different than that of mTECs. This includes both the enzymes utilized to generate
peptides from proteins (Nakagawa et al., 1998), as well as the phagocytic versus
autophagy pathway by which antigens are routed to the MHCII presentation pathway in
DCs versus mTECs, respectively (Aichinger et al., 2013; Joffre et al., 2012). Second,
the receptors used by CD8+ DCs appear to be the same between the thymus and the
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periphery. In fact, the decision to test CD36 and Gpr105 was based on gene-chip data
from both peripheral and thymic CD8+/CD103+ DCs, suggesting that presentation of
apoptotic antigens may be a shared feature of thymic and peripheral CD8+ DCs. Third,
cross-dressing of MHC molecules was originally described in the periphery (Wakim and
Bevan, 2011). It is therefore tempting to speculate that this process is similar to what we
have observed in the thymus. Taken together, the process of antigen transfer in the
thymus may not represent a specialized interaction, but simply the use of peripheral
antigen presentation mechanisms to standardize the generation of self-epitopes seen
by immature and mature T cells.
The mechanism utilized by CD8+ DCs to acquire cell-surface antigens from
mTECs appears to be the recognition of apoptotic bodies by CD36. CD36 is specifically
expressed on thymic CD8+ DCs but not SIRP+ or pDCs, and is reported to bind PS
present on apoptotic bodies. We found in TCR repertoire analysis that CD36 was
involved in both negative selection and Treg cell differentiation with a strong bias toward
co-dependence with Batf3 and Aire, implying that CD36 plays a role in antigen transfer
to CD8+ DCs. In addition, absence of CD36 resulted in the loss of CD8+ DC
acquisition and presentation of membrane-bound I-Eantigen from mTECs in vivo.
Finally, deficiency in the purinergic receptor Gpr105, which recognizes the “find-me”
signal UDP released by apoptotic cells, decreased CD8+ DC presentation of cellsurface-bound antigen acquired from mTECs. Taken together, these data suggest a
model in which mTECs mature, express Aire, and ultimately undergo apoptosis to
generate bodies that are recognized by CD36 on CD8+ DCs.
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Transfer and presentation of cell-surface proteins on MHCII could occur via at
least two distinct mechanisms. First, I-E could be phagocytosed/endocytosed where it
is degraded in the lysosome and loaded onto MHCII. Alternatively, cell-surface proteins
could be directly transferred from one membrane to another in a process akin to
trogocytosis. For MHCI presentation in the periphery, this process has been termed
“cross-dressing.” Internalization of transferred cell-surface proteins can then result in
peptide presentation on MHCII. Although we cannot currently exclude a role for
phagocytosis, our data suggest that CD36-mediated antigen transfer results in “crossdressing” as evidenced by its role in direct allo-tolerance during bone marrow
transplantation.
The observation that MHC is directly transferred to the CD8+ DC cell surface
brings up the possibility that mTEC-loaded peptide:MHC complexes directly mediate
negative selection or Treg cell differentiation (Koble and Kyewski, 2009). Alternatively,
mTEC-derived cell surface antigens can be internalized, degraded, and loaded onto
MHCII as detected by the peptide-in-groove antibody Y-Ae. This mechanism could
explain the observation of antigen transfer using the RIP-mOVA transgene (Koble and
Kyewski, 2009), which expresses a transmembrane protein conjugated to OVA peptide.
Understanding which cell-surface proteins transferred from mTECs has unfortunately
been limited by the possibility of cross-contamination during our thymic DC preparation
protocol. Future studies are required to determine the relative importance of CD8+
presentation of intact peptide/MHC transferred from mTECs versus internalization and
presentation of mTEC-associated cell-surface antigens.
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In addition to CD36-dependent transfer of cell-surface proteins, we also observed
transfer of cytoplasmic GFP from mTECs to CD8+ DCs via a CD36-independent
mechanism, demonstrating the existence of an additional antigen-transfer pathway. It
remains unresolved whether cytoplasmic antigen transfer involves a different mTECderived particle, as it remains possible that CD36 could be simply involved in the
transfer of cell-surface proteins from apoptotic blebs which go on to be internalized via
other mechanisms (Albert et al., 1998). Alternatively, uptake of different particles such
as exosomes versus apoptotic blebs from mTECs could favor cytoplasmic versus cellmembrane proteins. Future studies will be required to clarify the mechanism by which
cytoplasmic antigens are transferred.
In summary, these data suggest that antigen transfer from mTECs is mediated to
a large part by CD8+ DCs and is demonstrably important to thymic T cell tolerance. We
have also determined that CD36 facilitates direct transfer of MHC and presumably other
cell-surface proteins onto the cell surface of CD8+ DCs. One intriguing hypothesis is
that defects in this pathway may lead to loss of tolerance to cell-surface proteins,
potentially contributing to antibody mediated diseases such as Graves autoimmune
thyroiditis that target cell-surface receptors. In a similar vein, defects in the transfer of
cell-surface antigens might contribute to the loss of allo-tolerance during bone marrow
transplantation, resulting in chronic graft versus host disease.
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CHAPTER 4
Concluding Remarks and Discussion

There have been a number of recent advances in our understanding of how selfreactive thymocytes are deleted or selected to become Treg cells. Recent data suggest
that the medullary APCs subsets often function non-redundantly. pDCs and SIRP+
DCs appear more adept at acquiring and presenting peripheral and blood-borne
antigen, whereas mTECs and B cells present different arrays of Aire-dependent
peripheral tissue antigens. Recent data also highlight the cooperativity between the
APC subsets. Batf3-dependent CD8+ DCs appear to preferentially acquire antigen
from Aire+ mTECs to facilitate the development of thymic Treg cells. In fact, cooperative
antigen presentation of mTEC antigens transferred to BM APCs may be as important as
cell-autonomous mTEC antigen presentation.
However, a number of issues remain. First, identification of naturally occurring Treg
cell TCR ligands would be useful to address which APCs generate and present these
ligands and to determine the TCR affinity required for Treg and negative selection.
Second, quantification of the contribution of each APC subset, as well as the
importance of transport of extra-thymic antigens by migratory APC populations, to Treg
and negative selection is needed. Third, understanding the factors that determine the
utilization of mTEC-autonomous versus cooperative antigen transfer pathways for
tolerance would be important for understanding why and how antigen transfer occurs.
Finally, it is important to examine whether these mechanisms are regulated during
ontogeny such that certain periods of life favor tolerance versus immunity. Thus, future
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studies will seek to define the interaction of the thymic antigenic repertoire with the APC
subsets and the generation of thymic tolerance.
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